id	sid	tid	token	lemma	pos
aiua-10978	1	1	stesura	stesura	PROPN
aiua-10978	1	2	seveso	seveso	PROPN
aiua-10978	1	3	451archivio	451archivio	PROPN
aiua-10978	1	4	italiano	italiano	NOUN
aiua-10978	1	5	di	di	X
aiua-10978	1	6	urologia	urologia	PROPN
aiua-10978	1	7	e	e	PROPN
aiua-10978	1	8	andrologia	andrologia	PROPN
aiua-10978	1	9	2022	2022	NUM
aiua-10978	1	10	;	;	PUNCT
aiua-10978	1	11	94	94	NUM
aiua-10978	1	12	,	,	PUNCT
aiua-10978	1	13	4	4	NUM
aiua-10978	1	14	original	original	ADJ
aiua-10978	1	15	paper	paper	NOUN
aiua-10978	1	16	no	no	DET
aiua-10978	1	17	conflict	conflict	NOUN
aiua-10978	1	18	of	of	ADP
aiua-10978	1	19	interest	interest	NOUN
aiua-10978	1	20	declared	declare	VERB
aiua-10978	1	21	.	.	PUNCT
aiua-10978	2	1	11.8	11.8	NUM
aiua-10978	2	2	-	-	SYM
aiua-10978	2	3	24.7	24.7	NUM
aiua-10978	2	4	%	%	NOUN
aiua-10978	2	5	of	of	ADP
aiua-10978	2	6	adults	adult	NOUN
aiua-10978	2	7	in	in	ADP
aiua-10978	2	8	north	north	PROPN
aiua-10978	2	9	america	america	PROPN
aiua-10978	2	10	and	and	CCONJ
aiua-10978	2	11	europe	europe	PROPN
aiua-10978	2	12	,	,	PUNCT
aiua-10978	2	13	and	and	CCONJ
aiua-10978	2	14	its	its	PRON
aiua-10978	2	15	prevalence	prevalence	NOUN
aiua-10978	2	16	increases	increase	VERB
aiua-10978	2	17	with	with	ADP
aiua-10978	2	18	age	age	NOUN
aiua-10978	2	19	(	(	PUNCT
aiua-10978	2	20	3	3	NUM
aiua-10978	2	21	)	)	PUNCT
aiua-10978	2	22	.	.	PUNCT
aiua-10978	3	1	in	in	ADP
aiua-10978	3	2	addition	addition	NOUN
aiua-10978	3	3	to	to	ADP
aiua-10978	3	4	age	age	NOUN
aiua-10978	3	5	,	,	PUNCT
aiua-10978	3	6	the	the	DET
aiua-10978	3	7	risk	risk	NOUN
aiua-10978	3	8	factors	factor	NOUN
aiua-10978	3	9	for	for	ADP
aiua-10978	3	10	oab	oab	PROPN
aiua-10978	3	11	include	include	VERB
aiua-10978	3	12	diabetes	diabete	NOUN
aiua-10978	3	13	,	,	PUNCT
aiua-10978	3	14	uti	uti	PROPN
aiua-10978	3	15	,	,	PUNCT
aiua-10978	3	16	and	and	CCONJ
aiua-10978	3	17	obesity	obesity	NOUN
aiua-10978	3	18	(	(	PUNCT
aiua-10978	3	19	4	4	NUM
aiua-10978	3	20	,	,	PUNCT
aiua-10978	3	21	5	5	NUM
aiua-10978	3	22	)	)	PUNCT
aiua-10978	3	23	.	.	PUNCT
aiua-10978	4	1	pharmacotherapy	pharmacotherapy	NOUN
aiua-10978	4	2	is	be	AUX
aiua-10978	4	3	the	the	DET
aiua-10978	4	4	main	main	ADJ
aiua-10978	4	5	treatment	treatment	NOUN
aiua-10978	4	6	for	for	ADP
aiua-10978	4	7	oab	oab	PROPN
aiua-10978	4	8	in	in	ADP
aiua-10978	4	9	japan	japan	PROPN
aiua-10978	4	10	,	,	PUNCT
aiua-10978	4	11	and	and	CCONJ
aiua-10978	4	12	anticholinergic	anticholinergic	ADJ
aiua-10978	4	13	drugs	drug	NOUN
aiua-10978	4	14	are	be	AUX
aiua-10978	4	15	considered	consider	VERB
aiua-10978	4	16	to	to	PART
aiua-10978	4	17	be	be	AUX
aiua-10978	4	18	first	first	ADJ
aiua-10978	4	19	-	-	PUNCT
aiua-10978	4	20	line	line	NOUN
aiua-10978	4	21	drugs	drug	NOUN
aiua-10978	4	22	(	(	PUNCT
aiua-10978	4	23	6	6	NUM
aiua-10978	4	24	)	)	PUNCT
aiua-10978	4	25	.	.	PUNCT
aiua-10978	5	1	recently	recently	ADV
aiua-10978	5	2	,	,	PUNCT
aiua-10978	5	3	β3	β3	VERB
aiua-10978	5	4	adrenergic	adrenergic	ADJ
aiua-10978	5	5	agonists	agonist	NOUN
aiua-10978	5	6	,	,	PUNCT
aiua-10978	5	7	which	which	PRON
aiua-10978	5	8	have	have	VERB
aiua-10978	5	9	completely	completely	ADV
aiua-10978	5	10	different	different	ADJ
aiua-10978	5	11	mechanism	mechanism	NOUN
aiua-10978	5	12	of	of	ADP
aiua-10978	5	13	action	action	NOUN
aiua-10978	5	14	from	from	ADP
aiua-10978	5	15	anticholinergic	anticholinergic	ADJ
aiua-10978	5	16	drugs	drug	NOUN
aiua-10978	5	17	,	,	PUNCT
aiua-10978	5	18	have	have	AUX
aiua-10978	5	19	become	become	VERB
aiua-10978	5	20	available	available	ADJ
aiua-10978	5	21	and	and	CCONJ
aiua-10978	5	22	have	have	AUX
aiua-10978	5	23	been	be	AUX
aiua-10978	5	24	shown	show	VERB
aiua-10978	5	25	to	to	PART
aiua-10978	5	26	be	be	AUX
aiua-10978	5	27	effective	effective	ADJ
aiua-10978	5	28	.	.	PUNCT
aiua-10978	6	1	β3	β3	VERB
aiua-10978	6	2	adrenergic	adrenergic	ADJ
aiua-10978	6	3	agonists	agonist	NOUN
aiua-10978	6	4	were	be	AUX
aiua-10978	6	5	awarded	award	VERB
aiua-10978	6	6	a	a	DET
aiua-10978	6	7	grade	grade	NOUN
aiua-10978	6	8	-	-	PUNCT
aiua-10978	6	9	a	a	DET
aiua-10978	6	10	recommendation	recommendation	NOUN
aiua-10978	6	11	in	in	ADP
aiua-10978	6	12	the	the	DET
aiua-10978	6	13	japanese	japanese	ADJ
aiua-10978	6	14	oab	oab	PROPN
aiua-10978	6	15	treatment	treatment	NOUN
aiua-10978	6	16	guidelines	guideline	NOUN
aiua-10978	6	17	.	.	PUNCT
aiua-10978	7	1	however	however	ADV
aiua-10978	7	2	,	,	PUNCT
aiua-10978	7	3	no	no	DET
aiua-10978	7	4	study	study	NOUN
aiua-10978	7	5	on	on	ADP
aiua-10978	7	6	the	the	DET
aiua-10978	7	7	criteria	criterion	NOUN
aiua-10978	7	8	for	for	ADP
aiua-10978	7	9	choosing	choose	VERB
aiua-10978	7	10	between	between	ADP
aiua-10978	7	11	anticholinergics	anticholinergic	NOUN
aiua-10978	7	12	and	and	CCONJ
aiua-10978	7	13	β3	β3	VERB
aiua-10978	7	14	adrenergic	adrenergic	ADJ
aiua-10978	7	15	agonists	agonist	NOUN
aiua-10978	7	16	has	have	AUX
aiua-10978	7	17	been	be	AUX
aiua-10978	7	18	published	publish	VERB
aiua-10978	7	19	.	.	PUNCT
aiua-10978	8	1	when	when	SCONJ
aiua-10978	8	2	treating	treat	VERB
aiua-10978	8	3	patients	patient	NOUN
aiua-10978	8	4	with	with	ADP
aiua-10978	8	5	oab	oab	PROPN
aiua-10978	8	6	,	,	PUNCT
aiua-10978	8	7	how	how	SCONJ
aiua-10978	8	8	do	do	AUX
aiua-10978	8	9	clinicians	clinician	NOUN
aiua-10978	8	10	choose	choose	VERB
aiua-10978	8	11	among	among	ADP
aiua-10978	8	12	these	these	DET
aiua-10978	8	13	medications	medication	NOUN
aiua-10978	8	14	,	,	PUNCT
aiua-10978	8	15	which	which	PRON
aiua-10978	8	16	both	both	PRON
aiua-10978	8	17	have	have	VERB
aiua-10978	8	18	grade	grade	NOUN
aiua-10978	8	19	-	-	PUNCT
aiua-10978	8	20	a	a	DET
aiua-10978	8	21	recommendations	recommendation	NOUN
aiua-10978	8	22	and	and	CCONJ
aiua-10978	8	23	exhibit	exhibit	VERB
aiua-10978	8	24	comparable	comparable	ADJ
aiua-10978	8	25	therapeutic	therapeutic	ADJ
aiua-10978	8	26	efficacy	efficacy	NOUN
aiua-10978	8	27	?	?	PUNCT
aiua-10978	9	1	are	be	AUX
aiua-10978	9	2	there	there	PRON
aiua-10978	9	3	any	any	DET
aiua-10978	9	4	factors	factor	NOUN
aiua-10978	9	5	that	that	PRON
aiua-10978	9	6	influence	influence	VERB
aiua-10978	9	7	the	the	DET
aiua-10978	9	8	selection	selection	NOUN
aiua-10978	9	9	of	of	ADP
aiua-10978	9	10	these	these	DET
aiua-10978	9	11	medications	medication	NOUN
aiua-10978	9	12	?	?	PUNCT
aiua-10978	10	1	in	in	ADP
aiua-10978	10	2	the	the	DET
aiua-10978	10	3	present	present	ADJ
aiua-10978	10	4	study	study	NOUN
aiua-10978	10	5	,	,	PUNCT
aiua-10978	10	6	we	we	PRON
aiua-10978	10	7	investigated	investigate	VERB
aiua-10978	10	8	the	the	DET
aiua-10978	10	9	factors	factor	NOUN
aiua-10978	10	10	that	that	PRON
aiua-10978	10	11	influence	influence	VERB
aiua-10978	10	12	the	the	DET
aiua-10978	10	13	selection	selection	NOUN
aiua-10978	10	14	of	of	ADP
aiua-10978	10	15	anticholinergic	anticholinergic	ADJ
aiua-10978	10	16	drugs	drug	NOUN
aiua-10978	10	17	or	or	CCONJ
aiua-10978	10	18	β3	β3	VERB
aiua-10978	10	19	adrenergic	adrenergic	ADJ
aiua-10978	10	20	agonists	agonist	NOUN
aiua-10978	10	21	for	for	ADP
aiua-10978	10	22	oab	oab	PROPN
aiua-10978	10	23	in	in	ADP
aiua-10978	10	24	the	the	DET
aiua-10978	10	25	real	real	ADJ
aiua-10978	10	26	world	world	NOUN
aiua-10978	10	27	practice	practice	NOUN
aiua-10978	10	28	.	.	PUNCT
aiua-10978	11	1	materials	material	NOUN
aiua-10978	11	2	and	and	CCONJ
aiua-10978	11	3	methods	method	NOUN
aiua-10978	11	4	this	this	PRON
aiua-10978	11	5	was	be	AUX
aiua-10978	11	6	a	a	DET
aiua-10978	11	7	retrospective	retrospective	ADJ
aiua-10978	11	8	study	study	NOUN
aiua-10978	11	9	,	,	PUNCT
aiua-10978	11	10	which	which	PRON
aiua-10978	11	11	used	use	VERB
aiua-10978	11	12	data	datum	NOUN
aiua-10978	11	13	extracted	extract	VERB
aiua-10978	11	14	from	from	ADP
aiua-10978	11	15	electronic	electronic	ADJ
aiua-10978	11	16	records	record	NOUN
aiua-10978	11	17	.	.	PUNCT
aiua-10978	12	1	seventy	seventy	NUM
aiua-10978	12	2	-	-	PUNCT
aiua-10978	12	3	five	five	NUM
aiua-10978	12	4	who	who	PRON
aiua-10978	12	5	were	be	AUX
aiua-10978	12	6	diagnosed	diagnose	VERB
aiua-10978	12	7	with	with	ADP
aiua-10978	12	8	oab	oab	PROPN
aiua-10978	12	9	at	at	ADP
aiua-10978	12	10	the	the	DET
aiua-10978	12	11	department	department	PROPN
aiua-10978	12	12	of	of	ADP
aiua-10978	12	13	urology	urology	NOUN
aiua-10978	12	14	,	,	PUNCT
aiua-10978	12	15	teikyo	teikyo	PROPN
aiua-10978	12	16	university	university	PROPN
aiua-10978	12	17	chiba	chiba	PROPN
aiua-10978	12	18	medical	medical	PROPN
aiua-10978	12	19	center	center	PROPN
aiua-10978	12	20	(	(	PUNCT
aiua-10978	12	21	ichihara	ichihara	PROPN
aiua-10978	12	22	,	,	PUNCT
aiua-10978	12	23	japan	japan	PROPN
aiua-10978	12	24	)	)	PUNCT
aiua-10978	12	25	,	,	PUNCT
aiua-10978	12	26	between	between	ADP
aiua-10978	12	27	january	january	PROPN
aiua-10978	12	28	2013	2013	NUM
aiua-10978	12	29	and	and	CCONJ
aiua-10978	12	30	december	december	PROPN
aiua-10978	12	31	2014	2014	NUM
aiua-10978	12	32	were	be	AUX
aiua-10978	12	33	included	include	VERB
aiua-10978	12	34	in	in	ADP
aiua-10978	12	35	this	this	DET
aiua-10978	12	36	study	study	NOUN
aiua-10978	12	37	.	.	PUNCT
aiua-10978	13	1	the	the	DET
aiua-10978	13	2	overactive	overactive	ADJ
aiua-10978	13	3	bladder	bladder	NOUN
aiua-10978	13	4	symptoms	symptom	NOUN
aiua-10978	13	5	score	score	VERB
aiua-10978	13	6	(	(	PUNCT
aiua-10978	13	7	oabss	oabss	NOUN
aiua-10978	13	8	)	)	PUNCT
aiua-10978	13	9	was	be	AUX
aiua-10978	13	10	calculated	calculate	VERB
aiua-10978	13	11	for	for	ADP
aiua-10978	13	12	each	each	DET
aiua-10978	13	13	patient	patient	NOUN
aiua-10978	13	14	,	,	PUNCT
aiua-10978	13	15	and	and	CCONJ
aiua-10978	13	16	all	all	PRON
aiua-10978	13	17	of	of	ADP
aiua-10978	13	18	the	the	DET
aiua-10978	13	19	patients	patient	NOUN
aiua-10978	13	20	met	meet	VERB
aiua-10978	13	21	the	the	DET
aiua-10978	13	22	diagnostic	diagnostic	ADJ
aiua-10978	13	23	criteria	criterion	NOUN
aiua-10978	13	24	for	for	ADP
aiua-10978	13	25	oab	oab	PROPN
aiua-10978	13	26	.	.	PUNCT
aiua-10978	14	1	oab	oab	PROPN
aiua-10978	14	2	was	be	AUX
aiua-10978	14	3	diagnosed	diagnose	VERB
aiua-10978	14	4	based	base	VERB
aiua-10978	14	5	on	on	ADP
aiua-10978	14	6	the	the	DET
aiua-10978	14	7	oabss	oabss	NOUN
aiua-10978	14	8	or	or	CCONJ
aiua-10978	14	9	the	the	DET
aiua-10978	14	10	presence	presence	NOUN
aiua-10978	14	11	of	of	ADP
aiua-10978	14	12	urinary	urinary	ADJ
aiua-10978	14	13	urgency	urgency	NOUN
aiua-10978	14	14	(	(	PUNCT
aiua-10978	14	15	6	6	NUM
aiua-10978	14	16	)	)	PUNCT
aiua-10978	14	17	.	.	PUNCT
aiua-10978	15	1	the	the	DET
aiua-10978	15	2	oabss	oabss	NOUN
aiua-10978	15	3	is	be	AUX
aiua-10978	15	4	a	a	DET
aiua-10978	15	5	validated	validated	ADJ
aiua-10978	15	6	self	self	NOUN
aiua-10978	15	7	-	-	PUNCT
aiua-10978	15	8	assessed	assess	VERB
aiua-10978	15	9	questionnaire	questionnaire	NOUN
aiua-10978	15	10	created	create	VERB
aiua-10978	15	11	by	by	ADP
aiua-10978	15	12	the	the	DET
aiua-10978	15	13	japanese	japanese	ADJ
aiua-10978	15	14	continence	continence	NOUN
aiua-10978	15	15	society	society	NOUN
aiua-10978	15	16	and	and	CCONJ
aiua-10978	15	17	consists	consist	VERB
aiua-10978	15	18	of	of	ADP
aiua-10978	15	19	four	four	NUM
aiua-10978	15	20	questions	question	NOUN
aiua-10978	15	21	about	about	ADP
aiua-10978	15	22	oab	oab	PROPN
aiua-10978	15	23	symptoms	symptom	NOUN
aiua-10978	15	24	(	(	PUNCT
aiua-10978	15	25	q1	q1	PROPN
aiua-10978	15	26	:	:	PUNCT
aiua-10978	15	27	daytime	daytime	ADJ
aiua-10978	15	28	frequency	frequency	NOUN
aiua-10978	15	29	,	,	PUNCT
aiua-10978	15	30	q2	q2	NOUN
aiua-10978	15	31	:	:	PUNCT
aiua-10978	15	32	nighttime	nighttime	ADJ
aiua-10978	15	33	frequency	frequency	NOUN
aiua-10978	15	34	,	,	PUNCT
aiua-10978	15	35	q3	q3	PROPN
aiua-10978	15	36	:	:	PUNCT
aiua-10978	15	37	urgency	urgency	NOUN
aiua-10978	15	38	,	,	PUNCT
aiua-10978	15	39	and	and	CCONJ
aiua-10978	15	40	q4	q4	PROPN
aiua-10978	15	41	:	:	PUNCT
aiua-10978	15	42	urge	urge	VERB
aiua-10978	15	43	incontinence	incontinence	NOUN
aiua-10978	15	44	)	)	PUNCT
aiua-10978	15	45	(	(	PUNCT
aiua-10978	15	46	6	6	NUM
aiua-10978	15	47	)	)	PUNCT
aiua-10978	15	48	.	.	PUNCT
aiua-10978	16	1	we	we	PRON
aiua-10978	16	2	retrospectively	retrospectively	ADV
aiua-10978	16	3	evaluated	evaluate	VERB
aiua-10978	16	4	various	various	ADJ
aiua-10978	16	5	factors	factor	NOUN
aiua-10978	16	6	,	,	PUNCT
aiua-10978	16	7	including	include	VERB
aiua-10978	16	8	age	age	NOUN
aiua-10978	16	9	,	,	PUNCT
aiua-10978	16	10	administered	administer	VERB
aiua-10978	16	11	treatments	treatment	NOUN
aiua-10978	16	12	,	,	PUNCT
aiua-10978	16	13	body	body	NOUN
aiua-10978	16	14	mass	mass	NOUN
aiua-10978	16	15	index	index	NOUN
aiua-10978	16	16	(	(	PUNCT
aiua-10978	16	17	bmi	bmi	PROPN
aiua-10978	16	18	)	)	PUNCT
aiua-10978	16	19	,	,	PUNCT
aiua-10978	16	20	pretreatment	pretreatment	NOUN
aiua-10978	16	21	total	total	NOUN
aiua-10978	16	22	oabss	oabss	NOUN
aiua-10978	16	23	,	,	PUNCT
aiua-10978	16	24	pretreatment	pretreatment	NOUN
aiua-10978	16	25	score	score	NOUN
aiua-10978	16	26	for	for	ADP
aiua-10978	16	27	each	each	DET
aiua-10978	16	28	oabss	oabss	NOUN
aiua-10978	16	29	factor	factor	NOUN
aiua-10978	16	30	,	,	PUNCT
aiua-10978	16	31	post	post	ADJ
aiua-10978	16	32	-	-	ADJ
aiua-10978	16	33	voiding	voiding	ADJ
aiua-10978	16	34	residual	residual	ADJ
aiua-10978	16	35	volume	volume	NOUN
aiua-10978	16	36	(	(	PUNCT
aiua-10978	16	37	pvr	pvr	NOUN
aiua-10978	16	38	)	)	PUNCT
aiua-10978	16	39	,	,	PUNCT
aiua-10978	16	40	smoking	smoking	NOUN
aiua-10978	16	41	habits	habit	NOUN
aiua-10978	16	42	,	,	PUNCT
aiua-10978	16	43	presence	presence	NOUN
aiua-10978	16	44	or	or	CCONJ
aiua-10978	16	45	absence	absence	NOUN
aiua-10978	16	46	of	of	ADP
aiua-10978	16	47	hypertension	hypertension	NOUN
aiua-10978	16	48	,	,	PUNCT
aiua-10978	16	49	diabetes	diabetes	NOUN
aiua-10978	16	50	mellitus	mellitus	NOUN
aiua-10978	16	51	,	,	PUNCT
aiua-10978	16	52	and	and	CCONJ
aiua-10978	16	53	dyslipidemia	dyslipidemia	VERB
aiua-10978	16	54	.	.	PUNCT
aiua-10978	17	1	the	the	DET
aiua-10978	17	2	post	post	ADJ
aiua-10978	17	3	-	-	ADJ
aiua-10978	17	4	voiding	voiding	ADJ
aiua-10978	17	5	residual	residual	ADJ
aiua-10978	17	6	(	(	PUNCT
aiua-10978	17	7	pvr	pvr	NOUN
aiua-10978	17	8	)	)	PUNCT
aiua-10978	17	9	urine	urine	NOUN
aiua-10978	17	10	was	be	AUX
aiua-10978	17	11	measured	measure	VERB
aiua-10978	17	12	on	on	ADP
aiua-10978	17	13	a	a	DET
aiua-10978	17	14	transabdominal	transabdominal	ADJ
aiua-10978	17	15	ultrasonic	ultrasonic	ADJ
aiua-10978	17	16	echogram	echogram	NOUN
aiua-10978	17	17	in	in	ADP
aiua-10978	17	18	all	all	DET
aiua-10978	17	19	cases	case	NOUN
aiua-10978	17	20	.	.	PUNCT
aiua-10978	18	1	objective	objective	NOUN
aiua-10978	18	2	:	:	PUNCT
aiua-10978	18	3	the	the	DET
aiua-10978	18	4	reasons	reason	NOUN
aiua-10978	18	5	why	why	SCONJ
aiua-10978	18	6	anticholinergic	anticholinergic	ADJ
aiua-10978	18	7	drugs	drug	NOUN
aiua-10978	18	8	or	or	CCONJ
aiua-10978	18	9	β3	β3	VERB
aiua-10978	18	10	adrenergic	adrenergic	ADJ
aiua-10978	18	11	agonists	agonist	NOUN
aiua-10978	18	12	are	be	AUX
aiua-10978	18	13	selected	select	VERB
aiua-10978	18	14	as	as	ADP
aiua-10978	18	15	treatments	treatment	NOUN
aiua-10978	18	16	for	for	ADP
aiua-10978	18	17	overactive	overactive	ADJ
aiua-10978	18	18	bladder	bladder	NOUN
aiua-10978	18	19	(	(	PUNCT
aiua-10978	18	20	oab	oab	PROPN
aiua-10978	18	21	)	)	PUNCT
aiua-10978	18	22	are	be	AUX
aiua-10978	18	23	unclear	unclear	ADJ
aiua-10978	18	24	.	.	PUNCT
aiua-10978	19	1	the	the	DET
aiua-10978	19	2	aim	aim	NOUN
aiua-10978	19	3	of	of	ADP
aiua-10978	19	4	this	this	DET
aiua-10978	19	5	study	study	NOUN
aiua-10978	19	6	was	be	AUX
aiua-10978	19	7	to	to	PART
aiua-10978	19	8	investigate	investigate	VERB
aiua-10978	19	9	the	the	DET
aiua-10978	19	10	background	background	NOUN
aiua-10978	19	11	data	datum	NOUN
aiua-10978	19	12	of	of	ADP
aiua-10978	19	13	female	female	ADJ
aiua-10978	19	14	oab	oab	PROPN
aiua-10978	19	15	patients	patient	NOUN
aiua-10978	19	16	that	that	PRON
aiua-10978	19	17	were	be	AUX
aiua-10978	19	18	prescribed	prescribe	VERB
aiua-10978	19	19	anticholinergic	anticholinergic	ADJ
aiua-10978	19	20	drugs	drug	NOUN
aiua-10978	19	21	or	or	CCONJ
aiua-10978	19	22	β3	β3	VERB
aiua-10978	19	23	adrenergic	adrenergic	ADJ
aiua-10978	19	24	agonists	agonist	NOUN
aiua-10978	19	25	in	in	ADP
aiua-10978	19	26	a	a	DET
aiua-10978	19	27	real	real	ADJ
aiua-10978	19	28	-	-	PUNCT
aiua-10978	19	29	world	world	NOUN
aiua-10978	19	30	setting	setting	NOUN
aiua-10978	19	31	.	.	PUNCT
aiua-10978	20	1	materials	material	NOUN
aiua-10978	20	2	and	and	CCONJ
aiua-10978	20	3	methods	method	NOUN
aiua-10978	20	4	:	:	PUNCT
aiua-10978	20	5	between	between	ADP
aiua-10978	20	6	january	january	PROPN
aiua-10978	20	7	2013	2013	NUM
aiua-10978	20	8	and	and	CCONJ
aiua-10978	20	9	december	december	PROPN
aiua-10978	20	10	2014	2014	NUM
aiua-10978	20	11	,	,	PUNCT
aiua-10978	20	12	75	75	NUM
aiua-10978	20	13	patients	patient	NOUN
aiua-10978	20	14	who	who	PRON
aiua-10978	20	15	had	have	AUX
aiua-10978	20	16	been	be	AUX
aiua-10978	20	17	diagnosed	diagnose	VERB
aiua-10978	20	18	with	with	ADP
aiua-10978	20	19	oab	oab	PROPN
aiua-10978	20	20	were	be	AUX
aiua-10978	20	21	included	include	VERB
aiua-10978	20	22	in	in	ADP
aiua-10978	20	23	this	this	DET
aiua-10978	20	24	study	study	NOUN
aiua-10978	20	25	.	.	PUNCT
aiua-10978	21	1	administered	administer	VERB
aiua-10978	21	2	medications	medication	NOUN
aiua-10978	21	3	,	,	PUNCT
aiua-10978	21	4	age	age	NOUN
aiua-10978	21	5	,	,	PUNCT
aiua-10978	21	6	the	the	DET
aiua-10978	21	7	persistence	persistence	NOUN
aiua-10978	21	8	on	on	ADP
aiua-10978	21	9	treatment	treatment	NOUN
aiua-10978	21	10	rate	rate	NOUN
aiua-10978	21	11	at	at	ADP
aiua-10978	21	12	one	one	NUM
aiua-10978	21	13	-	-	PUNCT
aiua-10978	21	14	year	year	NOUN
aiua-10978	21	15	,	,	PUNCT
aiua-10978	21	16	medical	medical	ADJ
aiua-10978	21	17	history	history	NOUN
aiua-10978	21	18	,	,	PUNCT
aiua-10978	21	19	pretreatment	pretreatment	NOUN
aiua-10978	21	20	total	total	ADJ
aiua-10978	21	21	overactive	overactive	ADJ
aiua-10978	21	22	bladder	bladder	NOUN
aiua-10978	21	23	symptom	symptom	NOUN
aiua-10978	21	24	score	score	NOUN
aiua-10978	21	25	(	(	PUNCT
aiua-10978	21	26	oabss	oabss	NOUN
aiua-10978	21	27	)	)	PUNCT
aiua-10978	21	28	,	,	PUNCT
aiua-10978	21	29	pretreatment	pretreatment	NOUN
aiua-10978	21	30	score	score	NOUN
aiua-10978	21	31	for	for	ADP
aiua-10978	21	32	each	each	DET
aiua-10978	21	33	oabss	oabss	NOUN
aiua-10978	21	34	factor	factor	NOUN
aiua-10978	21	35	,	,	PUNCT
aiua-10978	21	36	body	body	NOUN
aiua-10978	21	37	mass	mass	NOUN
aiua-10978	21	38	index	index	NOUN
aiua-10978	21	39	(	(	PUNCT
aiua-10978	21	40	bmi	bmi	PROPN
aiua-10978	21	41	)	)	PUNCT
aiua-10978	21	42	,	,	PUNCT
aiua-10978	21	43	and	and	CCONJ
aiua-10978	21	44	various	various	ADJ
aiua-10978	21	45	comorbidities	comorbiditie	NOUN
aiua-10978	21	46	were	be	AUX
aiua-10978	21	47	evaluated	evaluate	VERB
aiua-10978	21	48	retrospectively	retrospectively	ADV
aiua-10978	21	49	.	.	PUNCT
aiua-10978	22	1	since	since	SCONJ
aiua-10978	22	2	there	there	PRON
aiua-10978	22	3	were	be	VERB
aiua-10978	22	4	many	many	ADJ
aiua-10978	22	5	types	type	NOUN
aiua-10978	22	6	of	of	ADP
aiua-10978	22	7	anticholinergic	anticholinergic	ADJ
aiua-10978	22	8	drugs	drug	NOUN
aiua-10978	22	9	and	and	CCONJ
aiua-10978	22	10	few	few	ADJ
aiua-10978	22	11	patients	patient	NOUN
aiua-10978	22	12	,	,	PUNCT
aiua-10978	22	13	we	we	PRON
aiua-10978	22	14	grouped	group	VERB
aiua-10978	22	15	the	the	DET
aiua-10978	22	16	patients	patient	NOUN
aiua-10978	22	17	into	into	ADP
aiua-10978	22	18	those	those	PRON
aiua-10978	22	19	that	that	PRON
aiua-10978	22	20	were	be	AUX
aiua-10978	22	21	prescribed	prescribe	VERB
aiua-10978	22	22	anticholinergic	anticholinergic	ADJ
aiua-10978	22	23	drugs	drug	NOUN
aiua-10978	22	24	(	(	PUNCT
aiua-10978	22	25	group	group	NOUN
aiua-10978	22	26	a	a	NOUN
aiua-10978	22	27	)	)	PUNCT
aiua-10978	22	28	and	and	CCONJ
aiua-10978	22	29	those	those	PRON
aiua-10978	22	30	that	that	PRON
aiua-10978	22	31	were	be	AUX
aiua-10978	22	32	prescribed	prescribe	VERB
aiua-10978	22	33	β3	β3	ADJ
aiua-10978	22	34	adrenergic	adrenergic	ADJ
aiua-10978	22	35	agonists	agonist	NOUN
aiua-10978	22	36	(	(	PUNCT
aiua-10978	22	37	group	group	NOUN
aiua-10978	22	38	b	b	NOUN
aiua-10978	22	39	)	)	PUNCT
aiua-10978	22	40	.	.	PUNCT
aiua-10978	23	1	results	result	NOUN
aiua-10978	23	2	:	:	PUNCT
aiua-10978	23	3	75	75	NUM
aiua-10978	23	4	patients	patient	NOUN
aiua-10978	23	5	(	(	PUNCT
aiua-10978	23	6	29	29	NUM
aiua-10978	23	7	in	in	ADP
aiua-10978	23	8	group	group	PROPN
aiua-10978	23	9	a	a	PROPN
aiua-10978	23	10	and	and	CCONJ
aiua-10978	23	11	46	46	NUM
aiua-10978	23	12	in	in	ADP
aiua-10978	23	13	group	group	PROPN
aiua-10978	23	14	b	b	PROPN
aiua-10978	23	15	)	)	PUNCT
aiua-10978	23	16	were	be	AUX
aiua-10978	23	17	included	include	VERB
aiua-10978	23	18	in	in	ADP
aiua-10978	23	19	this	this	DET
aiua-10978	23	20	study	study	NOUN
aiua-10978	23	21	.	.	PUNCT
aiua-10978	24	1	there	there	PRON
aiua-10978	24	2	were	be	VERB
aiua-10978	24	3	no	no	DET
aiua-10978	24	4	significant	significant	ADJ
aiua-10978	24	5	differences	difference	NOUN
aiua-10978	24	6	in	in	ADP
aiua-10978	24	7	age	age	NOUN
aiua-10978	24	8	,	,	PUNCT
aiua-10978	24	9	bmi	bmi	NOUN
aiua-10978	24	10	,	,	PUNCT
aiua-10978	24	11	obesity	obesity	NOUN
aiua-10978	24	12	,	,	PUNCT
aiua-10978	24	13	medical	medical	ADJ
aiua-10978	24	14	history	history	NOUN
aiua-10978	24	15	,	,	PUNCT
aiua-10978	24	16	pretreatment	pretreatment	NOUN
aiua-10978	24	17	total	total	NOUN
aiua-10978	24	18	oabss	oabss	NOUN
aiua-10978	24	19	,	,	PUNCT
aiua-10978	24	20	or	or	CCONJ
aiua-10978	24	21	pretreatment	pretreatment	NOUN
aiua-10978	24	22	score	score	NOUN
aiua-10978	24	23	for	for	ADP
aiua-10978	24	24	each	each	DET
aiua-10978	24	25	oabss	oabss	NOUN
aiua-10978	24	26	factor	factor	NOUN
aiua-10978	24	27	.	.	PUNCT
aiua-10978	25	1	there	there	PRON
aiua-10978	25	2	was	be	VERB
aiua-10978	25	3	a	a	DET
aiua-10978	25	4	significant	significant	ADJ
aiua-10978	25	5	difference	difference	NOUN
aiua-10978	25	6	in	in	ADP
aiua-10978	25	7	the	the	DET
aiua-10978	25	8	post	post	ADJ
aiua-10978	25	9	-	-	ADJ
aiua-10978	25	10	voiding	voiding	ADJ
aiua-10978	25	11	residual	residual	ADJ
aiua-10978	25	12	urine	urine	NOUN
aiua-10978	25	13	volume	volume	NOUN
aiua-10978	25	14	(	(	PUNCT
aiua-10978	25	15	pvr	pvr	NOUN
aiua-10978	25	16	)	)	PUNCT
aiua-10978	25	17	between	between	ADP
aiua-10978	25	18	the	the	DET
aiua-10978	25	19	groups	group	NOUN
aiua-10978	25	20	(	(	PUNCT
aiua-10978	25	21	group	group	NOUN
aiua-10978	25	22	a	a	X
aiua-10978	25	23	:	:	PUNCT
aiua-10978	25	24	22	22	NUM
aiua-10978	25	25	ml	ml	NOUN
aiua-10978	25	26	,	,	PUNCT
aiua-10978	25	27	group	group	NOUN
aiua-10978	25	28	b	b	NOUN
aiua-10978	25	29	:	:	PUNCT
aiua-10978	25	30	9	9	NUM
aiua-10978	25	31	ml	ml	NOUN
aiua-10978	25	32	;	;	PUNCT
aiua-10978	25	33	p	p	PROPN
aiua-10978	25	34	=	=	NOUN
aiua-10978	25	35	0.0252	0.0252	NUM
aiua-10978	25	36	)	)	PUNCT
aiua-10978	25	37	.	.	PUNCT
aiua-10978	26	1	the	the	DET
aiua-10978	26	2	1	1	NUM
aiua-10978	26	3	-	-	PUNCT
aiua-10978	26	4	year	year	NOUN
aiua-10978	26	5	persistence	persistence	NOUN
aiua-10978	26	6	on	on	ADP
aiua-10978	26	7	treatment	treatment	NOUN
aiua-10978	26	8	rate	rate	NOUN
aiua-10978	26	9	was	be	AUX
aiua-10978	26	10	28	28	NUM
aiua-10978	26	11	%	%	NOUN
aiua-10978	26	12	in	in	ADP
aiua-10978	26	13	both	both	DET
aiua-10978	26	14	groups	group	NOUN
aiua-10978	26	15	.	.	PUNCT
aiua-10978	27	1	conclusions	conclusion	NOUN
aiua-10978	27	2	:	:	PUNCT
aiua-10978	27	3	there	there	PRON
aiua-10978	27	4	were	be	VERB
aiua-10978	27	5	no	no	DET
aiua-10978	27	6	significant	significant	ADJ
aiua-10978	27	7	differences	difference	NOUN
aiua-10978	27	8	in	in	ADP
aiua-10978	27	9	clinical	clinical	ADJ
aiua-10978	27	10	characteristics	characteristic	NOUN
aiua-10978	27	11	of	of	ADP
aiua-10978	27	12	patients	patient	NOUN
aiua-10978	27	13	who	who	PRON
aiua-10978	27	14	were	be	AUX
aiua-10978	27	15	prescribed	prescribe	VERB
aiua-10978	27	16	anticholinergics	anticholinergic	NOUN
aiua-10978	27	17	and	and	CCONJ
aiua-10978	27	18	β3	β3	VERB
aiua-10978	27	19	adrenergic	adrenergic	ADJ
aiua-10978	27	20	agonists	agonist	NOUN
aiua-10978	27	21	for	for	ADP
aiua-10978	27	22	oab	oab	PROPN
aiua-10978	27	23	treatment	treatment	NOUN
aiua-10978	27	24	,	,	PUNCT
aiua-10978	27	25	but	but	CCONJ
aiua-10978	27	26	a	a	DET
aiua-10978	27	27	marginal	marginal	ADJ
aiua-10978	27	28	difference	difference	NOUN
aiua-10978	27	29	of	of	ADP
aiua-10978	27	30	pvr	pvr	NOUN
aiua-10978	27	31	value	value	NOUN
aiua-10978	27	32	before	before	ADP
aiua-10978	27	33	treatment	treatment	NOUN
aiua-10978	27	34	.	.	PUNCT
aiua-10978	28	1	the	the	DET
aiua-10978	28	2	1	1	NUM
aiua-10978	28	3	-	-	PUNCT
aiua-10978	28	4	year	year	NOUN
aiua-10978	28	5	persistence	persistence	NOUN
aiua-10978	28	6	rates	rate	NOUN
aiua-10978	28	7	of	of	ADP
aiua-10978	28	8	anticholinergic	anticholinergic	ADJ
aiua-10978	28	9	drugs	drug	NOUN
aiua-10978	28	10	and	and	CCONJ
aiua-10978	28	11	β3	β3	VERB
aiua-10978	28	12	adrenergic	adrenergic	ADJ
aiua-10978	28	13	agonists	agonist	NOUN
aiua-10978	28	14	were	be	AUX
aiua-10978	28	15	considered	consider	VERB
aiua-10978	28	16	to	to	PART
aiua-10978	28	17	be	be	AUX
aiua-10978	28	18	almost	almost	ADV
aiua-10978	28	19	equivalent	equivalent	ADJ
aiua-10978	28	20	.	.	PUNCT
aiua-10978	29	1	key	key	ADJ
aiua-10978	29	2	words	word	NOUN
aiua-10978	29	3	:	:	PUNCT
aiua-10978	29	4	overactive	overactive	ADJ
aiua-10978	29	5	bladder	bladder	NOUN
aiua-10978	29	6	;	;	PUNCT
aiua-10978	29	7	anti	anti	ADJ
aiua-10978	29	8	-	-	ADJ
aiua-10978	29	9	cholinergic	cholinergic	ADJ
aiua-10978	29	10	drugs	drug	NOUN
aiua-10978	29	11	;	;	PUNCT
aiua-10978	29	12	β3	β3	VERB
aiua-10978	29	13	adrenergic	adrenergic	ADJ
aiua-10978	29	14	agonists	agonist	NOUN
aiua-10978	29	15	;	;	PUNCT
aiua-10978	29	16	post	post	ADJ
aiua-10978	29	17	-	-	ADJ
aiua-10978	29	18	voiding	voiding	ADJ
aiua-10978	29	19	residual	residual	ADJ
aiua-10978	29	20	urine	urine	NOUN
aiua-10978	29	21	volume	volume	NOUN
aiua-10978	29	22	.	.	PUNCT
aiua-10978	30	1	submitted	submit	VERB
aiua-10978	30	2	28	28	NUM
aiua-10978	30	3	october	october	PROPN
aiua-10978	30	4	2022	2022	NUM
aiua-10978	30	5	;	;	PUNCT
aiua-10978	30	6	accepted	accept	VERB
aiua-10978	30	7	10	10	NUM
aiua-10978	30	8	november	november	PROPN
aiua-10978	30	9	2022	2022	NUM
aiua-10978	30	10	introduction	introduction	NOUN
aiua-10978	30	11	overactive	overactive	ADJ
aiua-10978	30	12	bladder	bladder	NOUN
aiua-10978	30	13	(	(	PUNCT
aiua-10978	30	14	oab	oab	PROPN
aiua-10978	30	15	)	)	PUNCT
aiua-10978	30	16	is	be	AUX
aiua-10978	30	17	a	a	DET
aiua-10978	30	18	condition	condition	NOUN
aiua-10978	30	19	with	with	ADP
aiua-10978	30	20	characteristic	characteristic	ADJ
aiua-10978	30	21	symptoms	symptom	NOUN
aiua-10978	30	22	of	of	ADP
aiua-10978	30	23	urinary	urinary	ADJ
aiua-10978	30	24	urgency	urgency	NOUN
aiua-10978	30	25	,	,	PUNCT
aiua-10978	30	26	usually	usually	ADV
aiua-10978	30	27	accompanied	accompany	VERB
aiua-10978	30	28	by	by	ADP
aiua-10978	30	29	increased	increase	VERB
aiua-10978	30	30	urinary	urinary	ADJ
aiua-10978	30	31	frequency	frequency	NOUN
aiua-10978	30	32	and	and	CCONJ
aiua-10978	30	33	nocturia	nocturia	PROPN
aiua-10978	30	34	,	,	PUNCT
aiua-10978	30	35	with	with	ADP
aiua-10978	30	36	or	or	CCONJ
aiua-10978	30	37	without	without	ADP
aiua-10978	30	38	urge	urge	NOUN
aiua-10978	30	39	incontinence	incontinence	NOUN
aiua-10978	30	40	,	,	PUNCT
aiua-10978	30	41	in	in	ADP
aiua-10978	30	42	the	the	DET
aiua-10978	30	43	absence	absence	NOUN
aiua-10978	30	44	of	of	ADP
aiua-10978	30	45	a	a	DET
aiua-10978	30	46	urinary	urinary	ADJ
aiua-10978	30	47	tract	tract	NOUN
aiua-10978	30	48	infection	infection	NOUN
aiua-10978	30	49	(	(	PUNCT
aiua-10978	30	50	uti	uti	PROPN
aiua-10978	30	51	)	)	PUNCT
aiua-10978	30	52	or	or	CCONJ
aiua-10978	30	53	any	any	DET
aiua-10978	30	54	other	other	ADJ
aiua-10978	30	55	obvious	obvious	ADJ
aiua-10978	30	56	pathology	pathology	NOUN
aiua-10978	30	57	(	(	PUNCT
aiua-10978	30	58	1	1	NUM
aiua-10978	30	59	)	)	PUNCT
aiua-10978	30	60	.	.	PUNCT
aiua-10978	31	1	it	it	PRON
aiua-10978	31	2	was	be	AUX
aiua-10978	31	3	observed	observe	VERB
aiua-10978	31	4	that	that	SCONJ
aiua-10978	31	5	the	the	DET
aiua-10978	31	6	prevalence	prevalence	NOUN
aiua-10978	31	7	of	of	ADP
aiua-10978	31	8	oab	oab	PROPN
aiua-10978	31	9	among	among	ADP
aiua-10978	31	10	japanese	japanese	ADJ
aiua-10978	31	11	adults	adult	NOUN
aiua-10978	31	12	aged	age	VERB
aiua-10978	31	13	≥	≥	NUM
aiua-10978	31	14	40	40	NUM
aiua-10978	31	15	years	year	NOUN
aiua-10978	31	16	is	be	AUX
aiua-10978	31	17	12.4	12.4	NUM
aiua-10978	31	18	%	%	NOUN
aiua-10978	31	19	,	,	PUNCT
aiua-10978	31	20	and	and	CCONJ
aiua-10978	31	21	the	the	DET
aiua-10978	31	22	estimated	estimate	VERB
aiua-10978	31	23	number	number	NOUN
aiua-10978	31	24	of	of	ADP
aiua-10978	31	25	patients	patient	NOUN
aiua-10978	31	26	with	with	ADP
aiua-10978	31	27	oab	oab	PROPN
aiua-10978	31	28	is	be	AUX
aiua-10978	31	29	8.1	8.1	NUM
aiua-10978	31	30	million	million	NUM
aiua-10978	31	31	(	(	PUNCT
aiua-10978	31	32	2	2	NUM
aiua-10978	31	33	)	)	PUNCT
aiua-10978	31	34	.	.	PUNCT
aiua-10978	32	1	oab	oab	PROPN
aiua-10978	32	2	affects	affect	VERB
aiua-10978	32	3	the	the	DET
aiua-10978	32	4	choice	choice	NOUN
aiua-10978	32	5	of	of	ADP
aiua-10978	32	6	therapeutic	therapeutic	ADJ
aiua-10978	32	7	agent	agent	NOUN
aiua-10978	32	8	in	in	ADP
aiua-10978	32	9	female	female	ADJ
aiua-10978	32	10	overactive	overactive	ADJ
aiua-10978	32	11	bladder	bladder	NOUN
aiua-10978	32	12	patients	patient	NOUN
aiua-10978	32	13	in	in	ADP
aiua-10978	32	14	real	real	ADJ
aiua-10978	32	15	-	-	PUNCT
aiua-10978	32	16	world	world	NOUN
aiua-10978	32	17	practice	practice	NOUN
aiua-10978	32	18	hiroshi	hiroshi	PROPN
aiua-10978	32	19	masuda	masuda	PROPN
aiua-10978	32	20	,	,	PUNCT
aiua-10978	32	21	kosuke	kosuke	PROPN
aiua-10978	32	22	mikami	mikami	PROPN
aiua-10978	32	23	,	,	PUNCT
aiua-10978	32	24	kotaro	kotaro	PROPN
aiua-10978	32	25	otsuka	otsuka	PROPN
aiua-10978	32	26	,	,	PUNCT
aiua-10978	32	27	kyokusin	kyokusin	PROPN
aiua-10978	32	28	hou	hou	PROPN
aiua-10978	32	29	,	,	PUNCT
aiua-10978	32	30	takahito	takahito	NOUN
aiua-10978	32	31	suyama	suyama	NOUN
aiua-10978	32	32	,	,	PUNCT
aiua-10978	32	33	kazuhiro	kazuhiro	PROPN
aiua-10978	32	34	araki	araki	PROPN
aiua-10978	32	35	,	,	PUNCT
aiua-10978	32	36	satoko	satoko	PROPN
aiua-10978	32	37	kojima	kojima	PROPN
aiua-10978	32	38	,	,	PUNCT
aiua-10978	32	39	yukio	yukio	PROPN
aiua-10978	32	40	naya	naya	PROPN
aiua-10978	32	41	department	department	PROPN
aiua-10978	32	42	of	of	ADP
aiua-10978	32	43	urology	urology	NOUN
aiua-10978	32	44	,	,	PUNCT
aiua-10978	32	45	teikyo	teikyo	PROPN
aiua-10978	32	46	university	university	PROPN
aiua-10978	32	47	chiba	chiba	PROPN
aiua-10978	32	48	medical	medical	PROPN
aiua-10978	32	49	center	center	NOUN
aiua-10978	32	50	,	,	PUNCT
aiua-10978	32	51	3426	3426	NUM
aiua-10978	32	52	-	-	SYM
aiua-10978	32	53	3	3	NUM
aiua-10978	32	54	anesaki	anesaki	NOUN
aiua-10978	32	55	,	,	PUNCT
aiua-10978	32	56	ichihara	ichihara	PROPN
aiua-10978	32	57	,	,	PUNCT
aiua-10978	32	58	chiba	chiba	PROPN
aiua-10978	32	59	299	299	NUM
aiua-10978	32	60	-	-	SYM
aiua-10978	32	61	0111	0111	NUM
aiua-10978	32	62	,	,	PUNCT
aiua-10978	32	63	japan	japan	PROPN
aiua-10978	32	64	.	.	PUNCT
aiua-10978	33	1	doi	doi	PROPN
aiua-10978	33	2	:	:	PUNCT
aiua-10978	33	3	10.4081	10.4081	NUM
aiua-10978	33	4	/	/	SYM
aiua-10978	33	5	aiua.2022.4.451	aiua.2022.4.451	NOUN
aiua-10978	33	6	summary	summary	VERB
aiua-10978	33	7	archivio	archivio	NOUN
aiua-10978	33	8	italiano	italiano	X
aiua-10978	33	9	di	di	X
aiua-10978	33	10	urologia	urologia	PROPN
aiua-10978	33	11	e	e	PROPN
aiua-10978	33	12	andrologia	andrologia	PROPN
aiua-10978	33	13	2022	2022	NUM
aiua-10978	33	14	;	;	PUNCT
aiua-10978	33	15	94	94	NUM
aiua-10978	33	16	,	,	PUNCT
aiua-10978	33	17	4	4	NUM
aiua-10978	33	18	h.	h.	PROPN
aiua-10978	33	19	masuda	masuda	PROPN
aiua-10978	33	20	,	,	PUNCT
aiua-10978	33	21	k.	k.	PROPN
aiua-10978	33	22	mikami	mikami	PROPN
aiua-10978	33	23	,	,	PUNCT
aiua-10978	33	24	k.	k.	PROPN
aiua-10978	33	25	otsuka	otsuka	PROPN
aiua-10978	33	26	,	,	PUNCT
aiua-10978	33	27	k.	k.	PROPN
aiua-10978	33	28	hou	hou	PROPN
aiua-10978	33	29	,	,	PUNCT
aiua-10978	33	30	t.	t.	NOUN
aiua-10978	33	31	suyama	suyama	NOUN
aiua-10978	33	32	,	,	PUNCT
aiua-10978	33	33	k.	k.	PROPN
aiua-10978	33	34	araki	araki	PROPN
aiua-10978	33	35	,	,	PUNCT
aiua-10978	33	36	s.	s.	PROPN
aiua-10978	33	37	kojima	kojima	PROPN
aiua-10978	33	38	,	,	PUNCT
aiua-10978	33	39	y.	y.	PROPN
aiua-10978	33	40	naya	naya	PROPN
aiua-10978	33	41	452	452	NUM
aiua-10978	33	42	regarding	regard	VERB
aiua-10978	33	43	the	the	DET
aiua-10978	33	44	administered	administer	VERB
aiua-10978	33	45	medications	medication	NOUN
aiua-10978	33	46	,	,	PUNCT
aiua-10978	33	47	since	since	SCONJ
aiua-10978	33	48	many	many	ADJ
aiua-10978	33	49	kinds	kind	NOUN
aiua-10978	33	50	of	of	ADP
aiua-10978	33	51	anticholinergic	anticholinergic	ADJ
aiua-10978	33	52	drugs	drug	NOUN
aiua-10978	33	53	were	be	AUX
aiua-10978	33	54	administered	administer	VERB
aiua-10978	33	55	in	in	ADP
aiua-10978	33	56	small	small	ADJ
aiua-10978	33	57	groups	group	NOUN
aiua-10978	33	58	of	of	ADP
aiua-10978	33	59	patients	patient	NOUN
aiua-10978	33	60	,	,	PUNCT
aiua-10978	33	61	patients	patient	NOUN
aiua-10978	33	62	were	be	AUX
aiua-10978	33	63	categorized	categorize	VERB
aiua-10978	33	64	into	into	ADP
aiua-10978	33	65	two	two	NUM
aiua-10978	33	66	groups	group	NOUN
aiua-10978	33	67	as	as	ADP
aiua-10978	33	68	those	those	PRON
aiua-10978	33	69	treated	treat	VERB
aiua-10978	33	70	with	with	ADP
aiua-10978	33	71	anticholinergic	anticholinergic	ADJ
aiua-10978	33	72	drugs	drug	NOUN
aiua-10978	33	73	(	(	PUNCT
aiua-10978	33	74	group	group	NOUN
aiua-10978	33	75	a	a	NOUN
aiua-10978	33	76	)	)	PUNCT
aiua-10978	33	77	and	and	CCONJ
aiua-10978	33	78	those	those	PRON
aiua-10978	33	79	treated	treat	VERB
aiua-10978	33	80	with	with	ADP
aiua-10978	33	81	β3	β3	ADJ
aiua-10978	33	82	adrenergic	adrenergic	ADJ
aiua-10978	33	83	agonists	agonist	NOUN
aiua-10978	33	84	(	(	PUNCT
aiua-10978	33	85	group	group	NOUN
aiua-10978	33	86	b	b	NOUN
aiua-10978	33	87	)	)	PUNCT
aiua-10978	33	88	.	.	PUNCT
aiua-10978	34	1	the	the	DET
aiua-10978	34	2	patients	patient	NOUN
aiua-10978	34	3	were	be	AUX
aiua-10978	34	4	allowed	allow	VERB
aiua-10978	34	5	to	to	PART
aiua-10978	34	6	discontinue	discontinue	VERB
aiua-10978	34	7	their	their	PRON
aiua-10978	34	8	medication	medication	NOUN
aiua-10978	34	9	during	during	ADP
aiua-10978	34	10	the	the	DET
aiua-10978	34	11	follow	follow	NOUN
aiua-10978	34	12	-	-	PUNCT
aiua-10978	34	13	up	up	NOUN
aiua-10978	34	14	period	period	NOUN
aiua-10978	34	15	,	,	PUNCT
aiua-10978	34	16	according	accord	VERB
aiua-10978	34	17	to	to	ADP
aiua-10978	34	18	their	their	PRON
aiua-10978	34	19	desires	desire	NOUN
aiua-10978	34	20	and	and	CCONJ
aiua-10978	34	21	the	the	DET
aiua-10978	34	22	judgement	judgement	NOUN
aiua-10978	34	23	of	of	ADP
aiua-10978	34	24	the	the	DET
aiua-10978	34	25	attending	attend	VERB
aiua-10978	34	26	physician	physician	NOUN
aiua-10978	34	27	.	.	PUNCT
aiua-10978	35	1	we	we	PRON
aiua-10978	35	2	investigated	investigate	VERB
aiua-10978	35	3	the	the	DET
aiua-10978	35	4	continuation	continuation	NOUN
aiua-10978	35	5	/	/	SYM
aiua-10978	35	6	discontinuation	discontinuation	NOUN
aiua-10978	35	7	of	of	ADP
aiua-10978	35	8	anticholinergic	anticholinergic	ADJ
aiua-10978	35	9	drug	drug	NOUN
aiua-10978	35	10	and	and	CCONJ
aiua-10978	35	11	β3	β3	VERB
aiua-10978	35	12	adrenergic	adrenergic	ADJ
aiua-10978	35	13	agonist	agonist	NOUN
aiua-10978	35	14	treatment	treatment	NOUN
aiua-10978	35	15	.	.	PUNCT
aiua-10978	36	1	although	although	SCONJ
aiua-10978	36	2	we	we	PRON
aiua-10978	36	3	could	could	AUX
aiua-10978	36	4	not	not	PART
aiua-10978	36	5	examine	examine	VERB
aiua-10978	36	6	the	the	DET
aiua-10978	36	7	reasons	reason	NOUN
aiua-10978	36	8	for	for	ADP
aiua-10978	36	9	discontinuation	discontinuation	NOUN
aiua-10978	36	10	.	.	PUNCT
aiua-10978	37	1	statistical	statistical	ADJ
aiua-10978	37	2	analysis	analysis	NOUN
aiua-10978	37	3	statistical	statistical	ADJ
aiua-10978	37	4	analyses	analysis	NOUN
aiua-10978	37	5	were	be	AUX
aiua-10978	37	6	carried	carry	VERB
aiua-10978	37	7	out	out	ADP
aiua-10978	37	8	to	to	PART
aiua-10978	37	9	identify	identify	VERB
aiua-10978	37	10	clinical	clinical	ADJ
aiua-10978	37	11	parameters	parameter	NOUN
aiua-10978	37	12	that	that	PRON
aiua-10978	37	13	differed	differ	VERB
aiua-10978	37	14	significantly	significantly	ADV
aiua-10978	37	15	between	between	ADP
aiua-10978	37	16	groups	group	NOUN
aiua-10978	37	17	a	a	PRON
aiua-10978	37	18	and	and	CCONJ
aiua-10978	37	19	b.	b.	X
aiua-10978	38	1	the	the	DET
aiua-10978	38	2	results	result	NOUN
aiua-10978	38	3	are	be	AUX
aiua-10978	38	4	shown	show	VERB
aiua-10978	38	5	as	as	ADP
aiua-10978	38	6	mean	mean	NOUN
aiua-10978	38	7	±	±	NUM
aiua-10978	38	8	se	se	X
aiua-10978	38	9	or	or	CCONJ
aiua-10978	38	10	percentage	percentage	NOUN
aiua-10978	38	11	.	.	PUNCT
aiua-10978	39	1	the	the	DET
aiua-10978	39	2	mann	mann	PROPN
aiua-10978	39	3	-	-	PUNCT
aiua-10978	39	4	whitney	whitney	PROPN
aiua-10978	39	5	u	u	PROPN
aiua-10978	39	6	test	test	NOUN
aiua-10978	39	7	and	and	CCONJ
aiua-10978	39	8	chi	chi	ADJ
aiua-10978	39	9	-	-	PUNCT
aiua-10978	39	10	squared	square	VERB
aiua-10978	39	11	test	test	NOUN
aiua-10978	39	12	were	be	AUX
aiua-10978	39	13	used	use	VERB
aiua-10978	39	14	for	for	ADP
aiua-10978	39	15	the	the	DET
aiua-10978	39	16	statistical	statistical	ADJ
aiua-10978	39	17	analyses	analysis	NOUN
aiua-10978	39	18	.	.	PUNCT
aiua-10978	40	1	all	all	DET
aiua-10978	40	2	analyses	analysis	NOUN
aiua-10978	40	3	were	be	AUX
aiua-10978	40	4	performed	perform	VERB
aiua-10978	40	5	with	with	ADP
aiua-10978	40	6	jmp	jmp	PROPN
aiua-10978	40	7	version	version	PROPN
aiua-10978	40	8	10	10	NUM
aiua-10978	40	9	(	(	PUNCT
aiua-10978	40	10	sas	sas	PROPN
aiua-10978	40	11	institute	institute	PROPN
aiua-10978	40	12	inc	inc	PROPN
aiua-10978	40	13	.	.	PROPN
aiua-10978	40	14	,	,	PUNCT
aiua-10978	40	15	cary	cary	PROPN
aiua-10978	40	16	,	,	PUNCT
aiua-10978	40	17	nc	nc	PROPN
aiua-10978	40	18	,	,	PUNCT
aiua-10978	40	19	usa	usa	PROPN
aiua-10978	40	20	)	)	PUNCT
aiua-10978	40	21	.	.	PUNCT
aiua-10978	41	1	a	a	DET
aiua-10978	41	2	probability	probability	NOUN
aiua-10978	41	3	value	value	NOUN
aiua-10978	41	4	of	of	ADP
aiua-10978	41	5	<	<	X
aiua-10978	41	6	0.05	0.05	NUM
aiua-10978	41	7	was	be	AUX
aiua-10978	41	8	considered	consider	VERB
aiua-10978	41	9	statistically	statistically	ADV
aiua-10978	41	10	significant	significant	ADJ
aiua-10978	41	11	.	.	PUNCT
aiua-10978	42	1	ethical	ethical	ADJ
aiua-10978	42	2	approval	approval	NOUN
aiua-10978	42	3	.	.	PUNCT
aiua-10978	43	1	the	the	DET
aiua-10978	43	2	institutional	institutional	ADJ
aiua-10978	43	3	review	review	PROPN
aiua-10978	43	4	board	board	NOUN
aiua-10978	43	5	of	of	ADP
aiua-10978	43	6	teikyo	teikyo	PROPN
aiua-10978	43	7	university	university	PROPN
aiua-10978	43	8	approved	approve	VERB
aiua-10978	43	9	this	this	DET
aiua-10978	43	10	study	study	NOUN
aiua-10978	43	11	(	(	PUNCT
aiua-10978	43	12	tuic	tuic	NOUN
aiua-10978	43	13	-	-	PUNCT
aiua-10978	43	14	coi	coi	NOUN
aiua-10978	43	15	21	21	NUM
aiua-10978	43	16	-	-	SYM
aiua-10978	43	17	1218	1218	NUM
aiua-10978	43	18	)	)	PUNCT
aiua-10978	43	19	.	.	PUNCT
aiua-10978	44	1	results	result	NOUN
aiua-10978	44	2	table	table	NOUN
aiua-10978	44	3	1	1	NUM
aiua-10978	44	4	shows	show	VERB
aiua-10978	44	5	the	the	DET
aiua-10978	44	6	patients	patient	NOUN
aiua-10978	44	7	’	’	PART
aiua-10978	44	8	background	background	NOUN
aiua-10978	44	9	characteristics	characteristic	NOUN
aiua-10978	44	10	.	.	PUNCT
aiua-10978	45	1	we	we	PRON
aiua-10978	45	2	evaluated	evaluate	VERB
aiua-10978	45	3	75	75	NUM
aiua-10978	45	4	patients	patient	NOUN
aiua-10978	45	5	(	(	PUNCT
aiua-10978	45	6	29	29	NUM
aiua-10978	45	7	in	in	ADP
aiua-10978	45	8	group	group	PROPN
aiua-10978	45	9	a	a	PROPN
aiua-10978	45	10	and	and	CCONJ
aiua-10978	45	11	46	46	NUM
aiua-10978	45	12	in	in	ADP
aiua-10978	45	13	group	group	PROPN
aiua-10978	45	14	b	b	PROPN
aiua-10978	45	15	)	)	PUNCT
aiua-10978	45	16	that	that	PRON
aiua-10978	45	17	were	be	AUX
aiua-10978	45	18	prescribed	prescribe	VERB
aiua-10978	45	19	anticholinergic	anticholinergic	ADJ
aiua-10978	45	20	drugs	drug	NOUN
aiua-10978	45	21	or	or	CCONJ
aiua-10978	45	22	β3	β3	VERB
aiua-10978	45	23	adrenergic	adrenergic	ADJ
aiua-10978	45	24	agonists	agonist	NOUN
aiua-10978	45	25	by	by	ADP
aiua-10978	45	26	our	our	PRON
aiua-10978	45	27	department	department	NOUN
aiua-10978	45	28	.	.	PUNCT
aiua-10978	46	1	there	there	PRON
aiua-10978	46	2	were	be	VERB
aiua-10978	46	3	no	no	DET
aiua-10978	46	4	significant	significant	ADJ
aiua-10978	46	5	differences	difference	NOUN
aiua-10978	46	6	in	in	ADP
aiua-10978	46	7	age	age	NOUN
aiua-10978	46	8	,	,	PUNCT
aiua-10978	46	9	bmi	bmi	NOUN
aiua-10978	46	10	,	,	PUNCT
aiua-10978	46	11	obesity	obesity	NOUN
aiua-10978	46	12	,	,	PUNCT
aiua-10978	46	13	medical	medical	ADJ
aiua-10978	46	14	history	history	NOUN
aiua-10978	46	15	,	,	PUNCT
aiua-10978	46	16	the	the	DET
aiua-10978	46	17	pretreatment	pretreatment	NOUN
aiua-10978	46	18	total	total	NOUN
aiua-10978	46	19	oabss	oabss	NOUN
aiua-10978	46	20	,	,	PUNCT
aiua-10978	46	21	or	or	CCONJ
aiua-10978	46	22	the	the	DET
aiua-10978	46	23	pretreatment	pretreatment	NOUN
aiua-10978	46	24	scores	score	NOUN
aiua-10978	46	25	for	for	ADP
aiua-10978	46	26	individual	individual	ADJ
aiua-10978	46	27	oabss	oabss	NOUN
aiua-10978	46	28	factors	factor	NOUN
aiua-10978	46	29	.	.	PUNCT
aiua-10978	47	1	the	the	DET
aiua-10978	47	2	mean	mean	ADJ
aiua-10978	47	3	pretreatment	pretreatment	NOUN
aiua-10978	47	4	pvr	pvr	NOUN
aiua-10978	47	5	was	be	AUX
aiua-10978	47	6	significantly	significantly	ADV
aiua-10978	47	7	greater	great	ADJ
aiua-10978	47	8	in	in	ADP
aiua-10978	47	9	group	group	NOUN
aiua-10978	47	10	a	a	PRON
aiua-10978	47	11	than	than	ADP
aiua-10978	47	12	in	in	ADP
aiua-10978	47	13	group	group	PROPN
aiua-10978	47	14	b	b	PROPN
aiua-10978	47	15	(	(	PUNCT
aiua-10978	47	16	22	22	NUM
aiua-10978	47	17	ml	ml	NOUN
aiua-10978	47	18	vs.	vs.	ADP
aiua-10978	47	19	9	9	NUM
aiua-10978	47	20	ml	ml	NOUN
aiua-10978	47	21	,	,	PUNCT
aiua-10978	47	22	respectively	respectively	ADV
aiua-10978	47	23	;	;	PUNCT
aiua-10978	47	24	p	p	PROPN
aiua-10978	47	25	=	=	NOUN
aiua-10978	47	26	0.0252	0.0252	NUM
aiua-10978	47	27	)	)	PUNCT
aiua-10978	47	28	(	(	PUNCT
aiua-10978	47	29	table	table	NOUN
aiua-10978	47	30	2	2	NUM
aiua-10978	47	31	)	)	PUNCT
aiua-10978	47	32	.	.	PUNCT
aiua-10978	48	1	a	a	DET
aiua-10978	48	2	younger	young	ADJ
aiua-10978	48	3	age	age	NOUN
aiua-10978	48	4	,	,	PUNCT
aiua-10978	48	5	a	a	DET
aiua-10978	48	6	lower	low	ADJ
aiua-10978	48	7	pretreatment	pretreatment	NOUN
aiua-10978	48	8	total	total	NOUN
aiua-10978	48	9	oabss	oabss	NOUN
aiua-10978	48	10	score	score	NOUN
aiua-10978	48	11	,	,	PUNCT
aiua-10978	48	12	table	table	NOUN
aiua-10978	48	13	1	1	NUM
aiua-10978	48	14	.	.	PUNCT
aiua-10978	48	15	patient	patient	ADJ
aiua-10978	48	16	characteristics	characteristic	NOUN
aiua-10978	48	17	.	.	PUNCT
aiua-10978	49	1	no	no	INTJ
aiua-10978	49	2	.	.	NOUN
aiua-10978	50	1	of	of	ADP
aiua-10978	50	2	patients	patient	NOUN
aiua-10978	50	3	n	n	NOUN
aiua-10978	50	4	=	=	SYM
aiua-10978	50	5	75	75	NUM
aiua-10978	50	6	age	age	NOUN
aiua-10978	50	7	(	(	PUNCT
aiua-10978	50	8	years	year	NOUN
aiua-10978	50	9	,	,	PUNCT
aiua-10978	50	10	mean	mean	VERB
aiua-10978	50	11	±	±	NUM
aiua-10978	50	12	se	se	X
aiua-10978	50	13	)	)	PUNCT
aiua-10978	50	14	70	70	NUM
aiua-10978	50	15	±	±	NUM
aiua-10978	50	16	1.4	1.4	NUM
aiua-10978	50	17	medication	medication	NOUN
aiua-10978	50	18	anticholinergics	anticholinergic	NOUN
aiua-10978	50	19	(	(	PUNCT
aiua-10978	50	20	n	n	CCONJ
aiua-10978	50	21	）	）	PROPN
aiua-10978	50	22	29	29	NUM
aiua-10978	50	23	propiverine	propiverine	NOUN
aiua-10978	50	24	3	3	NUM
aiua-10978	50	25	imidafenacin	imidafenacin	NOUN
aiua-10978	50	26	9	9	NUM
aiua-10978	50	27	fesoterodine	fesoterodine	NOUN
aiua-10978	50	28	6	6	NUM
aiua-10978	50	29	solifenacin	solifenacin	ADJ
aiua-10978	50	30	11	11	NUM
aiua-10978	50	31	β3	β3	NOUN
aiua-10978	50	32	adrenergic	adrenergic	ADJ
aiua-10978	50	33	agonists	agonist	NOUN
aiua-10978	50	34	46	46	NUM
aiua-10978	50	35	body	body	NOUN
aiua-10978	50	36	mass	mass	NOUN
aiua-10978	50	37	index	index	NOUN
aiua-10978	50	38	(	(	PUNCT
aiua-10978	50	39	kg	kg	NOUN
aiua-10978	50	40	/	/	SYM
aiua-10978	50	41	m2	m2	PROPN
aiua-10978	50	42	,	,	PUNCT
aiua-10978	50	43	mean	mean	VERB
aiua-10978	50	44	±	±	NUM
aiua-10978	50	45	se	se	X
aiua-10978	50	46	)	)	PUNCT
aiua-10978	50	47	28.2	28.2	NUM
aiua-10978	50	48	±	±	NUM
aiua-10978	50	49	0.3	0.3	NUM
aiua-10978	50	50	oabss	oabss	NOUN
aiua-10978	50	51	daytime	daytime	NOUN
aiua-10978	50	52	frequency	frequency	NOUN
aiua-10978	50	53	1.0	1.0	NUM
aiua-10978	50	54	±	±	NUM
aiua-10978	50	55	0.1	0.1	NUM
aiua-10978	50	56	nighttime	nighttime	NOUN
aiua-10978	50	57	frequency	frequency	NOUN
aiua-10978	50	58	2.4	2.4	NUM
aiua-10978	50	59	±	±	NUM
aiua-10978	50	60	0.1	0.1	NUM
aiua-10978	50	61	urgency	urgency	NOUN
aiua-10978	50	62	2.9	2.9	NUM
aiua-10978	50	63	±	±	NOUN
aiua-10978	50	64	0.2	0.2	NUM
aiua-10978	50	65	urge	urge	VERB
aiua-10978	50	66	incontinence	incontinence	NOUN
aiua-10978	50	67	1.7	1.7	NUM
aiua-10978	50	68	±	±	NUM
aiua-10978	50	69	0.2	0.2	NUM
aiua-10978	50	70	total	total	NOUN
aiua-10978	50	71	score	score	NOUN
aiua-10978	50	72	8.1	8.1	NUM
aiua-10978	50	73	±	±	NUM
aiua-10978	50	74	0.5	0.5	NUM
aiua-10978	50	75	pvr	pvr	NOUN
aiua-10978	50	76	(	(	PUNCT
aiua-10978	50	77	ml	ml	NOUN
aiua-10978	50	78	,	,	PUNCT
aiua-10978	50	79	mean	mean	VERB
aiua-10978	50	80	±	±	NUM
aiua-10978	50	81	se	se	X
aiua-10978	50	82	)	)	PUNCT
aiua-10978	50	83	14	14	NUM
aiua-10978	50	84	±	±	NUM
aiua-10978	50	85	2.6	2.6	NUM
aiua-10978	50	86	smoking	smoking	NOUN
aiua-10978	50	87	positive	positive	ADJ
aiua-10978	50	88	/	/	SYM
aiua-10978	50	89	negative	negative	ADJ
aiua-10978	50	90	7/68	7/68	NUM
aiua-10978	50	91	alcohol	alcohol	NOUN
aiua-10978	50	92	consumption	consumption	NOUN
aiua-10978	50	93	positive	positive	ADJ
aiua-10978	50	94	/	/	SYM
aiua-10978	50	95	negative	negative	ADJ
aiua-10978	50	96	7/68	7/68	NUM
aiua-10978	50	97	hypertension	hypertension	NOUN
aiua-10978	50	98	positive	positive	ADJ
aiua-10978	50	99	/	/	SYM
aiua-10978	50	100	negative	negative	ADJ
aiua-10978	50	101	38/37	38/37	NUM
aiua-10978	50	102	diabetes	diabetes	NOUN
aiua-10978	50	103	mellitus	mellitus	NOUN
aiua-10978	50	104	positive	positive	ADJ
aiua-10978	50	105	/	/	SYM
aiua-10978	50	106	negative	negative	ADJ
aiua-10978	50	107	10/65	10/65	NUM
aiua-10978	50	108	dyslipidemia	dyslipidemia	ADJ
aiua-10978	50	109	positive	positive	ADJ
aiua-10978	50	110	/	/	SYM
aiua-10978	50	111	negative	negative	ADJ
aiua-10978	50	112	24/51	24/51	NUM
aiua-10978	50	113	oabss	oabss	NOUN
aiua-10978	50	114	:	:	PUNCT
aiua-10978	50	115	overactive	overactive	ADJ
aiua-10978	50	116	bladder	bladder	NOUN
aiua-10978	50	117	symptom	symptom	NOUN
aiua-10978	50	118	score	score	NOUN
aiua-10978	50	119	;	;	PUNCT
aiua-10978	50	120	pvr	pvr	NOUN
aiua-10978	50	121	:	:	PUNCT
aiua-10978	50	122	post	post	ADJ
aiua-10978	50	123	-	-	ADJ
aiua-10978	50	124	voiding	voiding	ADJ
aiua-10978	50	125	residual	residual	ADJ
aiua-10978	50	126	urine	urine	NOUN
aiua-10978	50	127	volume	volume	NOUN
aiua-10978	50	128	.	.	PUNCT
aiua-10978	51	1	table	table	NOUN
aiua-10978	51	2	2	2	NUM
aiua-10978	51	3	.	.	PUNCT
aiua-10978	51	4	comparisons	comparison	NOUN
aiua-10978	51	5	between	between	ADP
aiua-10978	51	6	the	the	DET
aiua-10978	51	7	groups	group	NOUN
aiua-10978	51	8	.	.	PUNCT
aiua-10978	52	1	variable	variable	ADJ
aiua-10978	52	2	group	group	PROPN
aiua-10978	52	3	a	a	X
aiua-10978	52	4	(	(	PUNCT
aiua-10978	52	5	n	n	NOUN
aiua-10978	52	6	=	=	SYM
aiua-10978	52	7	29	29	NUM
aiua-10978	52	8	)	)	PUNCT
aiua-10978	52	9	group	group	NOUN
aiua-10978	52	10	b	b	PROPN
aiua-10978	52	11	(	(	PUNCT
aiua-10978	52	12	n	n	NOUN
aiua-10978	52	13	=	=	SYM
aiua-10978	52	14	46	46	NUM
aiua-10978	52	15	)	)	PUNCT
aiua-10978	52	16	p	p	X
aiua-10978	52	17	-	-	PUNCT
aiua-10978	52	18	value	value	NOUN
aiua-10978	52	19	age	age	NOUN
aiua-10978	52	20	(	(	PUNCT
aiua-10978	52	21	years	year	NOUN
aiua-10978	52	22	,	,	PUNCT
aiua-10978	52	23	mean	mean	VERB
aiua-10978	52	24	±	±	NUM
aiua-10978	52	25	se	se	X
aiua-10978	52	26	)	)	PUNCT
aiua-10978	52	27	69	69	NUM
aiua-10978	52	28	±	±	NUM
aiua-10978	52	29	1.4	1.4	NUM
aiua-10978	52	30	71	71	NUM
aiua-10978	52	31	±	±	NUM
aiua-10978	52	32	1.7	1.7	NUM
aiua-10978	52	33	0.5029	0.5029	NUM
aiua-10978	52	34	body	body	NOUN
aiua-10978	52	35	mass	mass	NOUN
aiua-10978	52	36	index	index	NOUN
aiua-10978	52	37	(	(	PUNCT
aiua-10978	52	38	kg	kg	NOUN
aiua-10978	52	39	/	/	SYM
aiua-10978	52	40	m2	m2	PROPN
aiua-10978	52	41	,	,	PUNCT
aiua-10978	52	42	mean	mean	VERB
aiua-10978	52	43	±	±	NUM
aiua-10978	52	44	se	se	X
aiua-10978	52	45	)	)	PUNCT
aiua-10978	52	46	28.2	28.2	NUM
aiua-10978	52	47	±	±	NUM
aiua-10978	52	48	0.5	0.5	NUM
aiua-10978	52	49	28.3	28.3	NUM
aiua-10978	52	50	±	±	NUM
aiua-10978	52	51	0.3	0.3	NUM
aiua-10978	52	52	0.6414	0.6414	NUM
aiua-10978	52	53	oabss	oabss	NOUN
aiua-10978	52	54	daytime	daytime	NOUN
aiua-10978	52	55	frequency	frequency	NOUN
aiua-10978	52	56	1.1	1.1	NUM
aiua-10978	52	57	±	±	NUM
aiua-10978	52	58	0.1	0.1	NUM
aiua-10978	52	59	1.0	1.0	NUM
aiua-10978	52	60	±	±	NUM
aiua-10978	52	61	0.1	0.1	NUM
aiua-10978	52	62	0.2736	0.2736	NUM
aiua-10978	52	63	nighttime	nighttime	NOUN
aiua-10978	52	64	frequency	frequency	NOUN
aiua-10978	52	65	2.5	2.5	NUM
aiua-10978	52	66	±	±	NUM
aiua-10978	52	67	0.1	0.1	NUM
aiua-10978	52	68	2.4	2.4	NUM
aiua-10978	52	69	±	±	NUM
aiua-10978	52	70	0.1	0.1	NUM
aiua-10978	52	71	0.7708	0.7708	NUM
aiua-10978	52	72	urgency	urgency	NOUN
aiua-10978	52	73	3.1	3.1	NUM
aiua-10978	52	74	±	±	NUM
aiua-10978	52	75	0.2	0.2	NUM
aiua-10978	52	76	2.8	2.8	NUM
aiua-10978	52	77	±	±	NUM
aiua-10978	52	78	0.3	0.3	NUM
aiua-10978	52	79	0.5017	0.5017	NUM
aiua-10978	52	80	urge	urge	NOUN
aiua-10978	52	81	incontinence	incontinence	NOUN
aiua-10978	52	82	2.1	2.1	NUM
aiua-10978	52	83	±	±	NUM
aiua-10978	52	84	0.2	0.2	NUM
aiua-10978	52	85	1.5	1.5	NUM
aiua-10978	52	86	±	±	NUM
aiua-10978	53	1	0.3	0.3	NUM
aiua-10978	53	2	0.1298	0.1298	NUM
aiua-10978	53	3	total	total	ADJ
aiua-10978	53	4	score	score	NOUN
aiua-10978	53	5	8.8	8.8	NUM
aiua-10978	53	6	±	±	NUM
aiua-10978	53	7	0.7	0.7	NUM
aiua-10978	53	8	7.7	7.7	NUM
aiua-10978	53	9	±	±	NUM
aiua-10978	53	10	0.6	0.6	NUM
aiua-10978	53	11	0.1639	0.1639	NUM
aiua-10978	53	12	pvr	pvr	NOUN
aiua-10978	53	13	(	(	PUNCT
aiua-10978	53	14	ml	ml	NOUN
aiua-10978	53	15	,	,	PUNCT
aiua-10978	53	16	mean	mean	VERB
aiua-10978	53	17	±	±	NUM
aiua-10978	53	18	se	se	X
aiua-10978	53	19	)	)	PUNCT
aiua-10978	53	20	22	22	NUM
aiua-10978	53	21	±	±	NUM
aiua-10978	53	22	5.8	5.8	NUM
aiua-10978	53	23	9.2	9.2	NUM
aiua-10978	53	24	±	±	NUM
aiua-10978	53	25	2.2	2.2	NUM
aiua-10978	53	26	0.0247	0.0247	NUM
aiua-10978	53	27	0	0	NUM
aiua-10978	53	28	-	-	SYM
aiua-10978	53	29	50	50	NUM
aiua-10978	53	30	ml/51	ml/51	NOUN
aiua-10978	53	31	-	-	PUNCT
aiua-10978	53	32	100	100	NUM
aiua-10978	53	33	ml/100	ml/100	NOUN
aiua-10978	53	34	ml	ml	ADP
aiua-10978	53	35	<	<	X
aiua-10978	53	36	26/3/0	26/3/0	NUM
aiua-10978	53	37	45/1/0	45/1/0	NUM
aiua-10978	53	38	0.1251	0.1251	NUM
aiua-10978	53	39	smoking	smoking	NOUN
aiua-10978	53	40	positive	positive	ADJ
aiua-10978	53	41	/	/	SYM
aiua-10978	53	42	negative	negative	ADJ
aiua-10978	53	43	4/25	4/25	NUM
aiua-10978	53	44	3/43	3/43	NUM
aiua-10978	53	45	0.151	0.151	NUM
aiua-10978	53	46	alcohol	alcohol	NOUN
aiua-10978	53	47	consumption	consumption	NOUN
aiua-10978	53	48	positive	positive	ADJ
aiua-10978	53	49	/	/	SYM
aiua-10978	53	50	negative	negative	ADJ
aiua-10978	53	51	2/27	2/27	NUM
aiua-10978	53	52	5/14	5/14	NUM
aiua-10978	53	53	0.3061	0.3061	NUM
aiua-10978	53	54	hypertension	hypertension	NOUN
aiua-10978	53	55	positive	positive	ADJ
aiua-10978	53	56	/	/	SYM
aiua-10978	53	57	negative	negative	ADJ
aiua-10978	53	58	13/16	13/16	NUM
aiua-10978	53	59	25/21	25/21	NUM
aiua-10978	53	60	0.4219	0.4219	NUM
aiua-10978	53	61	diabetes	diabetes	NOUN
aiua-10978	53	62	mellitus	mellitus	NOUN
aiua-10978	53	63	positive	positive	ADJ
aiua-10978	53	64	/	/	SYM
aiua-10978	53	65	negative	negative	ADJ
aiua-10978	53	66	3/26	3/26	NUM
aiua-10978	53	67	7/39	7/39	NUM
aiua-10978	53	68	0.5455	0.5455	NUM
aiua-10978	53	69	dyslipidemia	dyslipidemia	NOUN
aiua-10978	53	70	positive	positive	ADJ
aiua-10978	53	71	/	/	SYM
aiua-10978	53	72	negative	negative	ADJ
aiua-10978	53	73	7/22	7/22	NUM
aiua-10978	53	74	17/29	17/29	NUM
aiua-10978	53	75	0.2465	0.2465	NUM
aiua-10978	53	76	oabss	oabss	NOUN
aiua-10978	53	77	:	:	PUNCT
aiua-10978	53	78	overactive	overactive	ADJ
aiua-10978	53	79	bladder	bladder	NOUN
aiua-10978	53	80	symptom	symptom	NOUN
aiua-10978	53	81	score	score	NOUN
aiua-10978	53	82	;	;	PUNCT
aiua-10978	53	83	pvr	pvr	NOUN
aiua-10978	53	84	:	:	PUNCT
aiua-10978	53	85	post	post	ADJ
aiua-10978	53	86	-	-	ADJ
aiua-10978	53	87	voiding	voiding	ADJ
aiua-10978	53	88	residual	residual	ADJ
aiua-10978	53	89	urine	urine	NOUN
aiua-10978	53	90	volume	volume	NOUN
aiua-10978	53	91	.	.	PUNCT
aiua-10978	54	1	table	table	NOUN
aiua-10978	54	2	3	3	NUM
aiua-10978	54	3	.	.	NOUN
aiua-10978	54	4	assessment	assessment	NOUN
aiua-10978	54	5	of	of	ADP
aiua-10978	54	6	the	the	DET
aiua-10978	54	7	factors	factor	NOUN
aiua-10978	54	8	affecting	affect	VERB
aiua-10978	54	9	the	the	DET
aiua-10978	54	10	continuation	continuation	NOUN
aiua-10978	54	11	of	of	ADP
aiua-10978	54	12	medical	medical	ADJ
aiua-10978	54	13	treatment	treatment	NOUN
aiua-10978	54	14	.	.	PUNCT
aiua-10978	55	1	variable	variable	ADJ
aiua-10978	55	2	continuation	continuation	NOUN
aiua-10978	55	3	discontinuation	discontinuation	NOUN
aiua-10978	55	4	p	p	NOUN
aiua-10978	55	5	-	-	PUNCT
aiua-10978	55	6	value	value	NOUN
aiua-10978	55	7	group	group	NOUN
aiua-10978	55	8	(	(	PUNCT
aiua-10978	55	9	n	n	NOUN
aiua-10978	55	10	=	=	SYM
aiua-10978	55	11	21	21	NUM
aiua-10978	55	12	)	)	PUNCT
aiua-10978	55	13	group	group	NOUN
aiua-10978	55	14	(	(	PUNCT
aiua-10978	55	15	n	n	NOUN
aiua-10978	55	16	=	=	SYM
aiua-10978	55	17	54	54	NUM
aiua-10978	55	18	)	)	PUNCT
aiua-10978	55	19	age	age	NOUN
aiua-10978	55	20	(	(	PUNCT
aiua-10978	55	21	years	year	NOUN
aiua-10978	55	22	,	,	PUNCT
aiua-10978	55	23	mean	mean	VERB
aiua-10978	55	24	±	±	NUM
aiua-10978	55	25	se	se	X
aiua-10978	55	26	)	)	PUNCT
aiua-10978	55	27	74	74	NUM
aiua-10978	55	28	±	±	NUM
aiua-10978	55	29	1.4	1.4	NUM
aiua-10978	55	30	68	68	NUM
aiua-10978	55	31	±	±	NUM
aiua-10978	55	32	1.7	1.7	NUM
aiua-10978	55	33	0.2328	0.2328	NUM
aiua-10978	55	34	medication	medication	NOUN
aiua-10978	55	35	0.9495	0.9495	NUM
aiua-10978	55	36	anticholinergics	anticholinergic	NOUN
aiua-10978	55	37	8	8	NUM
aiua-10978	55	38	21	21	NUM
aiua-10978	55	39	mirabegron	mirabegron	PROPN
aiua-10978	55	40	13	13	NUM
aiua-10978	55	41	33	33	NUM
aiua-10978	55	42	body	body	NOUN
aiua-10978	55	43	mass	mass	NOUN
aiua-10978	55	44	index	index	NOUN
aiua-10978	55	45	(	(	PUNCT
aiua-10978	55	46	kg	kg	NOUN
aiua-10978	55	47	/	/	SYM
aiua-10978	55	48	m2	m2	PROPN
aiua-10978	55	49	,	,	PUNCT
aiua-10978	55	50	mean	mean	VERB
aiua-10978	55	51	±	±	NUM
aiua-10978	55	52	se	se	X
aiua-10978	55	53	)	)	PUNCT
aiua-10978	55	54	28.0	28.0	NUM
aiua-10978	55	55	±	±	NUM
aiua-10978	55	56	0.5	0.5	NUM
aiua-10978	55	57	28.3	28.3	NUM
aiua-10978	55	58	±	±	NUM
aiua-10978	55	59	0.3	0.3	NUM
aiua-10978	55	60	0.5236	0.5236	NUM
aiua-10978	55	61	oabss	oabss	NOUN
aiua-10978	55	62	daytime	daytime	NOUN
aiua-10978	55	63	frequency	frequency	NOUN
aiua-10978	55	64	1.2	1.2	NUM
aiua-10978	55	65	±	±	NUM
aiua-10978	55	66	0.1	0.1	NUM
aiua-10978	55	67	1.0	1.0	NUM
aiua-10978	55	68	±	±	NUM
aiua-10978	55	69	0.1	0.1	NUM
aiua-10978	55	70	0.201	0.201	NUM
aiua-10978	55	71	nighttime	nighttime	NOUN
aiua-10978	55	72	frequency	frequency	NOUN
aiua-10978	55	73	2.6	2.6	NUM
aiua-10978	55	74	±	±	NUM
aiua-10978	55	75	0.3	0.3	NUM
aiua-10978	55	76	2.4	2.4	NUM
aiua-10978	55	77	±	±	NUM
aiua-10978	55	78	0.1	0.1	NUM
aiua-10978	55	79	0.2912	0.2912	NUM
aiua-10978	55	80	urgency	urgency	NOUN
aiua-10978	55	81	2.8	2.8	NUM
aiua-10978	55	82	±	±	NUM
aiua-10978	55	83	0.4	0.4	NUM
aiua-10978	55	84	3.0	3.0	NUM
aiua-10978	55	85	±	±	NUM
aiua-10978	55	86	0.3	0.3	NUM
aiua-10978	55	87	0.5301	0.5301	NUM
aiua-10978	55	88	urge	urge	NOUN
aiua-10978	55	89	incontinence	incontinence	NOUN
aiua-10978	55	90	1.9	1.9	NUM
aiua-10978	55	91	±	±	NUM
aiua-10978	55	92	0.4	0.4	NUM
aiua-10978	55	93	1.7	1.7	NUM
aiua-10978	55	94	±	±	NUM
aiua-10978	55	95	0.3	0.3	NUM
aiua-10978	55	96	0.614	0.614	NUM
aiua-10978	55	97	total	total	ADJ
aiua-10978	55	98	score	score	NOUN
aiua-10978	55	99	8.6	8.6	NUM
aiua-10978	55	100	±	±	NUM
aiua-10978	55	101	0.9	0.9	NUM
aiua-10978	55	102	8.1	8.1	NUM
aiua-10978	55	103	±	±	NUM
aiua-10978	55	104	0.5	0.5	NUM
aiua-10978	55	105	0.8093	0.8093	NUM
aiua-10978	55	106	pvr	pvr	NOUN
aiua-10978	55	107	(	(	PUNCT
aiua-10978	55	108	ml	ml	NOUN
aiua-10978	55	109	,	,	PUNCT
aiua-10978	55	110	mean	mean	VERB
aiua-10978	55	111	±	±	NUM
aiua-10978	55	112	se	se	X
aiua-10978	55	113	)	)	PUNCT
aiua-10978	55	114	18	18	NUM
aiua-10978	55	115	±	±	NUM
aiua-10978	55	116	5.6	5.6	NUM
aiua-10978	55	117	12	12	NUM
aiua-10978	55	118	±	±	NUM
aiua-10978	55	119	3.0	3.0	NUM
aiua-10978	55	120	0.3325	0.3325	NUM
aiua-10978	55	121	smoking	smoking	NOUN
aiua-10978	55	122	positive	positive	ADJ
aiua-10978	55	123	/	/	SYM
aiua-10978	55	124	negative	negative	ADJ
aiua-10978	55	125	0/21	0/21	NUM
aiua-10978	55	126	7/47	7/47	NUM
aiua-10978	55	127	0.151	0.151	NUM
aiua-10978	55	128	alcohol	alcohol	NOUN
aiua-10978	55	129	consumption	consumption	NOUN
aiua-10978	55	130	positive	positive	ADJ
aiua-10978	55	131	/	/	SYM
aiua-10978	55	132	negative	negative	ADJ
aiua-10978	55	133	2/19	2/19	NUM
aiua-10978	55	134	5/49	5/49	NUM
aiua-10978	55	135	0.3061	0.3061	NUM
aiua-10978	55	136	hypertension	hypertension	NOUN
aiua-10978	55	137	positive	positive	ADJ
aiua-10978	55	138	/	/	SYM
aiua-10978	55	139	negative	negative	ADJ
aiua-10978	55	140	9/12	9/12	NUM
aiua-10978	55	141	29/25	29/25	NUM
aiua-10978	55	142	0.3989	0.3989	NUM
aiua-10978	55	143	diabetes	diabetes	NOUN
aiua-10978	55	144	mellitus	mellitus	NOUN
aiua-10978	55	145	positive	positive	ADJ
aiua-10978	55	146	/	/	SYM
aiua-10978	55	147	negative	negative	ADJ
aiua-10978	55	148	4/17	4/17	NUM
aiua-10978	55	149	6/48	6/48	NUM
aiua-10978	55	150	0.364	0.364	NUM
aiua-10978	55	151	dyslipidemia	dyslipidemia	NOUN
aiua-10978	55	152	positive	positive	ADJ
aiua-10978	55	153	/	/	SYM
aiua-10978	55	154	negative	negative	ADJ
aiua-10978	55	155	6/15	6/15	NUM
aiua-10978	55	156	18/36	18/36	NUM
aiua-10978	55	157	0.6914	0.6914	NUM
aiua-10978	55	158	oabss	oabss	NOUN
aiua-10978	55	159	:	:	PUNCT
aiua-10978	55	160	overactive	overactive	ADJ
aiua-10978	55	161	bladder	bladder	NOUN
aiua-10978	55	162	symptom	symptom	NOUN
aiua-10978	55	163	score	score	NOUN
aiua-10978	55	164	;	;	PUNCT
aiua-10978	55	165	pvr	pvr	NOUN
aiua-10978	55	166	:	:	PUNCT
aiua-10978	55	167	post	post	ADJ
aiua-10978	55	168	-	-	ADJ
aiua-10978	55	169	voiding	voiding	ADJ
aiua-10978	55	170	residual	residual	ADJ
aiua-10978	55	171	urine	urine	NOUN
aiua-10978	55	172	volume	volume	NOUN
aiua-10978	55	173	.	.	PUNCT
aiua-10978	56	1	453archivio	453archivio	NOUN
aiua-10978	56	2	italiano	italiano	NOUN
aiua-10978	56	3	di	di	NOUN
aiua-10978	56	4	urologia	urologia	PROPN
aiua-10978	56	5	e	e	PROPN
aiua-10978	56	6	andrologia	andrologia	PROPN
aiua-10978	56	7	2022	2022	NUM
aiua-10978	56	8	;	;	PUNCT
aiua-10978	56	9	94	94	NUM
aiua-10978	56	10	,	,	PUNCT
aiua-10978	56	11	4	4	NUM
aiua-10978	56	12	treatment	treatment	NOUN
aiua-10978	56	13	in	in	ADP
aiua-10978	56	14	female	female	ADJ
aiua-10978	56	15	oab	oab	PROPN
aiua-10978	56	16	and	and	CCONJ
aiua-10978	56	17	a	a	DET
aiua-10978	56	18	lower	low	ADJ
aiua-10978	56	19	pvr	pvr	NOUN
aiua-10978	56	20	were	be	AUX
aiua-10978	56	21	associated	associate	VERB
aiua-10978	56	22	with	with	ADP
aiua-10978	56	23	a	a	DET
aiua-10978	56	24	tendency	tendency	NOUN
aiua-10978	56	25	towards	towards	ADP
aiua-10978	56	26	medication	medication	NOUN
aiua-10978	56	27	discontinuation	discontinuation	NOUN
aiua-10978	56	28	.	.	PUNCT
aiua-10978	57	1	however	however	ADV
aiua-10978	57	2	,	,	PUNCT
aiua-10978	57	3	no	no	DET
aiua-10978	57	4	potential	potential	ADJ
aiua-10978	57	5	predictors	predictor	NOUN
aiua-10978	57	6	of	of	ADP
aiua-10978	57	7	discontinuation	discontinuation	NOUN
aiua-10978	57	8	differed	differ	VERB
aiua-10978	57	9	significantly	significantly	ADV
aiua-10978	57	10	between	between	ADP
aiua-10978	57	11	the	the	DET
aiua-10978	57	12	groups	group	NOUN
aiua-10978	57	13	(	(	PUNCT
aiua-10978	57	14	table	table	NOUN
aiua-10978	57	15	3	3	NUM
aiua-10978	57	16	)	)	PUNCT
aiua-10978	57	17	.	.	PUNCT
aiua-10978	58	1	the	the	DET
aiua-10978	58	2	one	one	NUM
aiua-10978	58	3	-	-	PUNCT
aiua-10978	58	4	year	year	NOUN
aiua-10978	58	5	persistence	persistence	NOUN
aiua-10978	58	6	rate	rate	NOUN
aiua-10978	58	7	of	of	ADP
aiua-10978	58	8	prescriptions	prescription	NOUN
aiua-10978	58	9	from	from	ADP
aiua-10978	58	10	our	our	PRON
aiua-10978	58	11	department	department	NOUN
aiua-10978	58	12	was	be	AUX
aiua-10978	58	13	28	28	NUM
aiua-10978	58	14	%	%	NOUN
aiua-10978	58	15	in	in	ADP
aiua-10978	58	16	both	both	DET
aiua-10978	58	17	groups	group	NOUN
aiua-10978	58	18	.	.	PUNCT
aiua-10978	59	1	discussion	discussion	NOUN
aiua-10978	59	2	in	in	ADP
aiua-10978	59	3	the	the	DET
aiua-10978	59	4	japanese	japanese	ADJ
aiua-10978	59	5	guidelines	guideline	NOUN
aiua-10978	59	6	for	for	ADP
aiua-10978	59	7	oab	oab	PROPN
aiua-10978	59	8	,	,	PUNCT
aiua-10978	59	9	anticholinergic	anticholinergic	ADJ
aiua-10978	59	10	drugs	drug	NOUN
aiua-10978	59	11	and	and	CCONJ
aiua-10978	59	12	β3	β3	VERB
aiua-10978	59	13	adrenergic	adrenergic	ADJ
aiua-10978	59	14	agonists	agonist	NOUN
aiua-10978	59	15	are	be	AUX
aiua-10978	59	16	given	give	VERB
aiua-10978	59	17	grade	grade	NOUN
aiua-10978	59	18	-	-	PUNCT
aiua-10978	59	19	a	a	DET
aiua-10978	59	20	recommendations	recommendation	NOUN
aiua-10978	59	21	as	as	ADP
aiua-10978	59	22	treatments	treatment	NOUN
aiua-10978	59	23	for	for	ADP
aiua-10978	59	24	oab	oab	PROPN
aiua-10978	59	25	(	(	PUNCT
aiua-10978	59	26	6	6	NUM
aiua-10978	59	27	)	)	PUNCT
aiua-10978	59	28	.	.	PUNCT
aiua-10978	60	1	however	however	ADV
aiua-10978	60	2	,	,	PUNCT
aiua-10978	60	3	while	while	SCONJ
aiua-10978	60	4	there	there	PRON
aiua-10978	60	5	has	have	AUX
aiua-10978	60	6	been	be	AUX
aiua-10978	60	7	some	some	DET
aiua-10978	60	8	debate	debate	NOUN
aiua-10978	60	9	about	about	ADP
aiua-10978	60	10	the	the	DET
aiua-10978	60	11	usage	usage	NOUN
aiua-10978	60	12	of	of	ADP
aiua-10978	60	13	different	different	ADJ
aiua-10978	60	14	anticholinergic	anticholinergic	ADJ
aiua-10978	60	15	drugs	drug	NOUN
aiua-10978	60	16	,	,	PUNCT
aiua-10978	60	17	there	there	PRON
aiua-10978	60	18	was	be	VERB
aiua-10978	60	19	insufficient	insufficient	ADJ
aiua-10978	60	20	discussion	discussion	NOUN
aiua-10978	60	21	and	and	CCONJ
aiua-10978	60	22	there	there	PRON
aiua-10978	60	23	are	be	VERB
aiua-10978	60	24	no	no	DET
aiua-10978	60	25	clear	clear	ADJ
aiua-10978	60	26	indicators	indicator	NOUN
aiua-10978	60	27	or	or	CCONJ
aiua-10978	60	28	guidelines	guideline	NOUN
aiua-10978	60	29	regarding	regard	VERB
aiua-10978	60	30	the	the	DET
aiua-10978	60	31	usage	usage	NOUN
aiua-10978	60	32	of	of	ADP
aiua-10978	60	33	anticholinergic	anticholinergic	ADJ
aiua-10978	60	34	drugs	drug	NOUN
aiua-10978	60	35	versus	versus	SCONJ
aiua-10978	60	36	β3	β3	VERB
aiua-10978	60	37	adrenergic	adrenergic	ADJ
aiua-10978	60	38	agonists	agonist	NOUN
aiua-10978	60	39	.	.	PUNCT
aiua-10978	61	1	therefore	therefore	ADV
aiua-10978	61	2	,	,	PUNCT
aiua-10978	61	3	individual	individual	ADJ
aiua-10978	61	4	medications	medication	NOUN
aiua-10978	61	5	are	be	AUX
aiua-10978	61	6	being	be	AUX
aiua-10978	61	7	administered	administer	VERB
aiua-10978	61	8	for	for	ADP
aiua-10978	61	9	oab	oab	PROPN
aiua-10978	61	10	without	without	ADP
aiua-10978	61	11	any	any	DET
aiua-10978	61	12	particular	particular	ADJ
aiua-10978	61	13	reason	reason	NOUN
aiua-10978	61	14	in	in	ADP
aiua-10978	61	15	real	real	ADJ
aiua-10978	61	16	-	-	PUNCT
aiua-10978	61	17	world	world	NOUN
aiua-10978	61	18	practice	practice	NOUN
aiua-10978	61	19	,	,	PUNCT
aiua-10978	61	20	and	and	CCONJ
aiua-10978	61	21	it	it	PRON
aiua-10978	61	22	seems	seem	VERB
aiua-10978	61	23	that	that	SCONJ
aiua-10978	61	24	choices	choice	NOUN
aiua-10978	61	25	between	between	ADP
aiua-10978	61	26	anticholinergic	anticholinergic	ADJ
aiua-10978	61	27	drugs	drug	NOUN
aiua-10978	61	28	and	and	CCONJ
aiua-10978	61	29	β3	β3	VERB
aiua-10978	61	30	adrenergic	adrenergic	ADJ
aiua-10978	61	31	agonists	agonist	NOUN
aiua-10978	61	32	are	be	AUX
aiua-10978	61	33	based	base	VERB
aiua-10978	61	34	on	on	ADP
aiua-10978	61	35	the	the	DET
aiua-10978	61	36	treating	treat	VERB
aiua-10978	61	37	doctor	doctor	NOUN
aiua-10978	61	38	’s	’s	PART
aiua-10978	61	39	preferences	preference	NOUN
aiua-10978	61	40	and	and	CCONJ
aiua-10978	61	41	experience	experience	NOUN
aiua-10978	61	42	.	.	PUNCT
aiua-10978	62	1	in	in	ADP
aiua-10978	62	2	the	the	DET
aiua-10978	62	3	present	present	ADJ
aiua-10978	62	4	study	study	NOUN
aiua-10978	62	5	,	,	PUNCT
aiua-10978	62	6	we	we	PRON
aiua-10978	62	7	investigated	investigate	VERB
aiua-10978	62	8	the	the	DET
aiua-10978	62	9	factors	factor	NOUN
aiua-10978	62	10	that	that	PRON
aiua-10978	62	11	influence	influence	VERB
aiua-10978	62	12	the	the	DET
aiua-10978	62	13	selection	selection	NOUN
aiua-10978	62	14	of	of	ADP
aiua-10978	62	15	anticholinergic	anticholinergic	ADJ
aiua-10978	62	16	drugs	drug	NOUN
aiua-10978	62	17	and	and	CCONJ
aiua-10978	62	18	β3	β3	VERB
aiua-10978	62	19	adrenergic	adrenergic	ADJ
aiua-10978	62	20	agonists	agonist	NOUN
aiua-10978	62	21	in	in	ADP
aiua-10978	62	22	the	the	DET
aiua-10978	62	23	real	real	ADJ
aiua-10978	62	24	-	-	PUNCT
aiua-10978	62	25	world	world	NOUN
aiua-10978	62	26	.	.	PUNCT
aiua-10978	63	1	to	to	ADP
aiua-10978	63	2	the	the	DET
aiua-10978	63	3	best	good	ADJ
aiua-10978	63	4	of	of	ADP
aiua-10978	63	5	our	our	PRON
aiua-10978	63	6	knowledge	knowledge	NOUN
aiua-10978	63	7	,	,	PUNCT
aiua-10978	63	8	this	this	PRON
aiua-10978	63	9	is	be	AUX
aiua-10978	63	10	the	the	DET
aiua-10978	63	11	first	first	ADJ
aiua-10978	63	12	study	study	NOUN
aiua-10978	63	13	to	to	PART
aiua-10978	63	14	investigate	investigate	VERB
aiua-10978	63	15	this	this	PRON
aiua-10978	63	16	among	among	ADP
aiua-10978	63	17	oab	oab	PROPN
aiua-10978	63	18	patients	patient	NOUN
aiua-10978	63	19	.	.	PUNCT
aiua-10978	64	1	safety	safety	NOUN
aiua-10978	64	2	safety	safety	NOUN
aiua-10978	64	3	is	be	AUX
aiua-10978	64	4	the	the	DET
aiua-10978	64	5	first	first	ADJ
aiua-10978	64	6	consideration	consideration	NOUN
aiua-10978	64	7	when	when	SCONJ
aiua-10978	64	8	selecting	select	VERB
aiua-10978	64	9	a	a	DET
aiua-10978	64	10	drug	drug	NOUN
aiua-10978	64	11	,	,	PUNCT
aiua-10978	64	12	and	and	CCONJ
aiua-10978	64	13	avoiding	avoid	VERB
aiua-10978	64	14	adverse	adverse	ADJ
aiua-10978	64	15	events	event	NOUN
aiua-10978	64	16	should	should	AUX
aiua-10978	64	17	be	be	AUX
aiua-10978	64	18	prioritized	prioritize	VERB
aiua-10978	64	19	over	over	ADP
aiua-10978	64	20	efficacy	efficacy	NOUN
aiua-10978	64	21	.	.	PUNCT
aiua-10978	65	1	β3	β3	VERB
aiua-10978	65	2	adrenergic	adrenergic	ADJ
aiua-10978	65	3	agonists	agonist	NOUN
aiua-10978	65	4	cause	cause	VERB
aiua-10978	65	5	side	side	NOUN
aiua-10978	65	6	effects	effect	NOUN
aiua-10978	65	7	,	,	PUNCT
aiua-10978	65	8	such	such	ADJ
aiua-10978	65	9	as	as	ADP
aiua-10978	65	10	dry	dry	ADJ
aiua-10978	65	11	mouth	mouth	NOUN
aiua-10978	65	12	and	and	CCONJ
aiua-10978	65	13	constipation	constipation	NOUN
aiua-10978	65	14	,	,	PUNCT
aiua-10978	65	15	less	less	ADV
aiua-10978	65	16	frequently	frequently	ADV
aiua-10978	65	17	than	than	ADP
aiua-10978	65	18	anticholinergic	anticholinergic	ADJ
aiua-10978	65	19	drugs	drug	NOUN
aiua-10978	65	20	.	.	PUNCT
aiua-10978	66	1	this	this	PRON
aiua-10978	66	2	should	should	AUX
aiua-10978	66	3	favor	favor	VERB
aiua-10978	66	4	the	the	DET
aiua-10978	66	5	selection	selection	NOUN
aiua-10978	66	6	of	of	ADP
aiua-10978	66	7	β3	β3	ADJ
aiua-10978	66	8	adrenergic	adrenergic	ADJ
aiua-10978	66	9	agonists	agonist	NOUN
aiua-10978	66	10	.	.	PUNCT
aiua-10978	67	1	regarding	regard	VERB
aiua-10978	67	2	dry	dry	ADJ
aiua-10978	67	3	mouth	mouth	NOUN
aiua-10978	67	4	,	,	PUNCT
aiua-10978	67	5	it	it	PRON
aiua-10978	67	6	has	have	AUX
aiua-10978	67	7	been	be	AUX
aiua-10978	67	8	reported	report	VERB
aiua-10978	67	9	that	that	SCONJ
aiua-10978	67	10	β3	β3	VERB
aiua-10978	67	11	adrenergic	adrenergic	ADJ
aiua-10978	67	12	agonists	agonist	NOUN
aiua-10978	67	13	cause	cause	VERB
aiua-10978	67	14	this	this	DET
aiua-10978	67	15	symptom	symptom	NOUN
aiua-10978	67	16	in	in	ADP
aiua-10978	67	17	33	33	NUM
aiua-10978	67	18	%	%	NOUN
aiua-10978	67	19	fewer	few	ADJ
aiua-10978	67	20	cases	case	NOUN
aiua-10978	67	21	than	than	ADP
aiua-10978	67	22	tolterodine	tolterodine	NOUN
aiua-10978	67	23	(	(	PUNCT
aiua-10978	67	24	7	7	NUM
aiua-10978	67	25	)	)	PUNCT
aiua-10978	67	26	.	.	PUNCT
aiua-10978	68	1	in	in	ADP
aiua-10978	68	2	another	another	DET
aiua-10978	68	3	study	study	NOUN
aiua-10978	68	4	,	,	PUNCT
aiua-10978	68	5	it	it	PRON
aiua-10978	68	6	was	be	AUX
aiua-10978	68	7	reported	report	VERB
aiua-10978	68	8	that	that	SCONJ
aiua-10978	68	9	the	the	DET
aiua-10978	68	10	incidence	incidence	NOUN
aiua-10978	68	11	of	of	ADP
aiua-10978	68	12	dry	dry	ADJ
aiua-10978	68	13	mouth	mouth	NOUN
aiua-10978	68	14	during	during	ADP
aiua-10978	68	15	β3	β3	ADJ
aiua-10978	68	16	adrenergic	adrenergic	ADJ
aiua-10978	68	17	agonist	agonist	NOUN
aiua-10978	68	18	treatment	treatment	NOUN
aiua-10978	68	19	was	be	AUX
aiua-10978	68	20	similar	similar	ADJ
aiua-10978	68	21	to	to	ADP
aiua-10978	68	22	that	that	PRON
aiua-10978	68	23	produced	produce	VERB
aiua-10978	68	24	by	by	ADP
aiua-10978	68	25	a	a	DET
aiua-10978	68	26	placebo	placebo	NOUN
aiua-10978	68	27	,	,	PUNCT
aiua-10978	68	28	and	and	CCONJ
aiua-10978	68	29	that	that	SCONJ
aiua-10978	68	30	it	it	PRON
aiua-10978	68	31	was	be	AUX
aiua-10978	68	32	associated	associate	VERB
aiua-10978	68	33	in	in	ADP
aiua-10978	68	34	one	one	NUM
aiua-10978	68	35	-	-	PUNCT
aiua-10978	68	36	fifth	fifth	NOUN
aiua-10978	68	37	of	of	ADP
aiua-10978	68	38	cases	case	NOUN
aiua-10978	68	39	with	with	ADP
aiua-10978	68	40	anticholinergic	anticholinergic	ADJ
aiua-10978	68	41	drugs	drug	NOUN
aiua-10978	68	42	(	(	PUNCT
aiua-10978	68	43	8)	8)	NUM
aiua-10978	68	44	.	.	PUNCT
aiua-10978	69	1	it	it	PRON
aiua-10978	69	2	has	have	AUX
aiua-10978	69	3	been	be	AUX
aiua-10978	69	4	observed	observe	VERB
aiua-10978	69	5	that	that	SCONJ
aiua-10978	69	6	dry	dry	ADJ
aiua-10978	69	7	mouth	mouth	NOUN
aiua-10978	69	8	is	be	AUX
aiua-10978	69	9	an	an	DET
aiua-10978	69	10	important	important	ADJ
aiua-10978	69	11	factor	factor	NOUN
aiua-10978	69	12	influencing	influence	VERB
aiua-10978	69	13	oral	oral	ADJ
aiua-10978	69	14	medication	medication	NOUN
aiua-10978	69	15	discontinuation	discontinuation	NOUN
aiua-10978	69	16	(	(	PUNCT
aiua-10978	69	17	9	9	NUM
aiua-10978	69	18	)	)	PUNCT
aiua-10978	69	19	.	.	PUNCT
aiua-10978	70	1	therefore	therefore	ADV
aiua-10978	70	2	,	,	PUNCT
aiua-10978	70	3	there	there	PRON
aiua-10978	70	4	is	be	VERB
aiua-10978	70	5	an	an	DET
aiua-10978	70	6	advantage	advantage	NOUN
aiua-10978	70	7	in	in	ADP
aiua-10978	70	8	choosing	choose	VERB
aiua-10978	70	9	β3	β3	ADP
aiua-10978	70	10	adrenergic	adrenergic	ADJ
aiua-10978	70	11	agonists	agonist	NOUN
aiua-10978	70	12	over	over	ADP
aiua-10978	70	13	anticholinergic	anticholinergic	ADJ
aiua-10978	70	14	drugs	drug	NOUN
aiua-10978	70	15	.	.	PUNCT
aiua-10978	71	1	it	it	PRON
aiua-10978	71	2	has	have	AUX
aiua-10978	71	3	also	also	ADV
aiua-10978	71	4	been	be	AUX
aiua-10978	71	5	reported	report	VERB
aiua-10978	71	6	that	that	SCONJ
aiua-10978	71	7	β3	β3	VERB
aiua-10978	71	8	adrenergic	adrenergic	ADJ
aiua-10978	71	9	agonists	agonist	NOUN
aiua-10978	71	10	have	have	VERB
aiua-10978	71	11	higher	high	ADJ
aiua-10978	71	12	persistence	persistence	NOUN
aiua-10978	71	13	rates	rate	NOUN
aiua-10978	71	14	than	than	ADP
aiua-10978	71	15	anticholinergics	anticholinergic	NOUN
aiua-10978	71	16	drugs	drug	NOUN
aiua-10978	71	17	and	and	CCONJ
aiua-10978	71	18	should	should	AUX
aiua-10978	71	19	be	be	AUX
aiua-10978	71	20	considered	consider	VERB
aiua-10978	71	21	for	for	ADP
aiua-10978	71	22	firstline	firstline	ADJ
aiua-10978	71	23	pharmacological	pharmacological	ADJ
aiua-10978	71	24	treatment	treatment	NOUN
aiua-10978	71	25	for	for	ADP
aiua-10978	71	26	oab	oab	PROPN
aiua-10978	71	27	(	(	PUNCT
aiua-10978	71	28	10	10	NUM
aiua-10978	71	29	)	)	PUNCT
aiua-10978	71	30	.	.	PUNCT
aiua-10978	72	1	furthermore	furthermore	ADV
aiua-10978	72	2	,	,	PUNCT
aiua-10978	72	3	it	it	PRON
aiua-10978	72	4	should	should	AUX
aiua-10978	72	5	be	be	AUX
aiua-10978	72	6	considered	consider	VERB
aiua-10978	72	7	that	that	SCONJ
aiua-10978	72	8	elderly	elderly	ADJ
aiua-10978	72	9	patients	patient	NOUN
aiua-10978	72	10	would	would	AUX
aiua-10978	72	11	be	be	AUX
aiua-10978	72	12	more	more	ADV
aiua-10978	72	13	likely	likely	ADJ
aiua-10978	72	14	to	to	PART
aiua-10978	72	15	be	be	AUX
aiua-10978	72	16	prescribed	prescribe	VERB
aiua-10978	72	17	β3	β3	ADJ
aiua-10978	72	18	adrenergic	adrenergic	ADJ
aiua-10978	72	19	agonists	agonist	NOUN
aiua-10978	72	20	than	than	ADP
aiua-10978	72	21	anticholinergics	anticholinergic	NOUN
aiua-10978	72	22	because	because	SCONJ
aiua-10978	72	23	of	of	ADP
aiua-10978	72	24	their	their	PRON
aiua-10978	72	25	high	high	ADJ
aiua-10978	72	26	frequency	frequency	NOUN
aiua-10978	72	27	of	of	ADP
aiua-10978	72	28	abnormal	abnormal	ADJ
aiua-10978	72	29	bowel	bowel	NOUN
aiua-10978	72	30	movements	movement	NOUN
aiua-10978	72	31	.	.	PUNCT
aiua-10978	73	1	finally	finally	ADV
aiua-10978	73	2	,	,	PUNCT
aiua-10978	73	3	it	it	PRON
aiua-10978	73	4	is	be	AUX
aiua-10978	73	5	likely	likely	ADJ
aiua-10978	73	6	that	that	SCONJ
aiua-10978	73	7	medications	medication	NOUN
aiua-10978	73	8	that	that	PRON
aiua-10978	73	9	involve	involve	VERB
aiua-10978	73	10	fewer	few	ADJ
aiua-10978	73	11	oral	oral	ADJ
aiua-10978	73	12	doses	dose	NOUN
aiua-10978	73	13	should	should	AUX
aiua-10978	73	14	be	be	AUX
aiua-10978	73	15	selected	select	VERB
aiua-10978	73	16	for	for	ADP
aiua-10978	73	17	elderly	elderly	ADJ
aiua-10978	73	18	patients	patient	NOUN
aiua-10978	73	19	because	because	SCONJ
aiua-10978	73	20	they	they	PRON
aiua-10978	73	21	may	may	AUX
aiua-10978	73	22	already	already	ADV
aiua-10978	73	23	be	be	AUX
aiua-10978	73	24	taking	take	VERB
aiua-10978	73	25	a	a	DET
aiua-10978	73	26	large	large	ADJ
aiua-10978	73	27	number	number	NOUN
aiua-10978	73	28	of	of	ADP
aiua-10978	73	29	medications	medication	NOUN
aiua-10978	73	30	.	.	PUNCT
aiua-10978	74	1	post	post	ADJ
aiua-10978	74	2	-	-	ADJ
aiua-10978	74	3	voiding	voiding	ADJ
aiua-10978	74	4	residual	residual	ADJ
aiua-10978	74	5	urine	urine	NOUN
aiua-10978	74	6	in	in	ADP
aiua-10978	74	7	a	a	DET
aiua-10978	74	8	comparative	comparative	ADJ
aiua-10978	74	9	study	study	NOUN
aiua-10978	74	10	of	of	ADP
aiua-10978	74	11	anticholinergic	anticholinergic	ADJ
aiua-10978	74	12	drugs	drug	NOUN
aiua-10978	74	13	and	and	CCONJ
aiua-10978	74	14	β3	β3	VERB
aiua-10978	74	15	adrenergic	adrenergic	ADJ
aiua-10978	74	16	agonists	agonist	NOUN
aiua-10978	74	17	,	,	PUNCT
aiua-10978	74	18	it	it	PRON
aiua-10978	74	19	was	be	AUX
aiua-10978	74	20	reported	report	VERB
aiua-10978	74	21	that	that	SCONJ
aiua-10978	74	22	there	there	PRON
aiua-10978	74	23	was	be	VERB
aiua-10978	74	24	no	no	DET
aiua-10978	74	25	significant	significant	ADJ
aiua-10978	74	26	difference	difference	NOUN
aiua-10978	74	27	in	in	ADP
aiua-10978	74	28	the	the	DET
aiua-10978	74	29	increase	increase	NOUN
aiua-10978	74	30	in	in	ADP
aiua-10978	74	31	the	the	DET
aiua-10978	74	32	pvr	pvr	NOUN
aiua-10978	74	33	seen	see	VERB
aiua-10978	74	34	during	during	ADP
aiua-10978	74	35	the	the	DET
aiua-10978	74	36	study	study	NOUN
aiua-10978	74	37	period	period	NOUN
aiua-10978	74	38	(	(	PUNCT
aiua-10978	74	39	0.86	0.86	NUM
aiua-10978	74	40	ml	ml	NOUN
aiua-10978	74	41	for	for	ADP
aiua-10978	74	42	the	the	DET
aiua-10978	74	43	placebo	placebo	NOUN
aiua-10978	74	44	,	,	PUNCT
aiua-10978	74	45	0.80	0.80	NUM
aiua-10978	74	46	ml	ml	NOUN
aiua-10978	74	47	for	for	ADP
aiua-10978	74	48	β3	β3	ADJ
aiua-10978	74	49	adrenergic	adrenergic	ADJ
aiua-10978	74	50	agonists	agonist	NOUN
aiua-10978	74	51	,	,	PUNCT
aiua-10978	74	52	and	and	CCONJ
aiua-10978	74	53	0.44	0.44	NUM
aiua-10978	74	54	ml	ml	NOUN
aiua-10978	74	55	for	for	ADP
aiua-10978	74	56	tolterodine	tolterodine	NOUN
aiua-10978	74	57	)	)	PUNCT
aiua-10978	74	58	(	(	PUNCT
aiua-10978	74	59	11	11	NUM
aiua-10978	74	60	)	)	PUNCT
aiua-10978	74	61	.	.	PUNCT
aiua-10978	75	1	moreover	moreover	ADV
aiua-10978	75	2	,	,	PUNCT
aiua-10978	75	3	stöhrer	stöhrer	PROPN
aiua-10978	75	4	et	et	PROPN
aiua-10978	75	5	al	al	PROPN
aiua-10978	75	6	.	.	PROPN
aiua-10978	75	7	reported	report	VERB
aiua-10978	75	8	that	that	SCONJ
aiua-10978	75	9	the	the	DET
aiua-10978	75	10	pvr	pvr	NOUN
aiua-10978	75	11	increased	increase	VERB
aiua-10978	75	12	significantly	significantly	ADV
aiua-10978	75	13	from	from	ADP
aiua-10978	75	14	50	50	NUM
aiua-10978	75	15	ml	ml	NOUN
aiua-10978	75	16	to	to	ADP
aiua-10978	75	17	87	87	NUM
aiua-10978	75	18	ml	ml	NOUN
aiua-10978	75	19	in	in	ADP
aiua-10978	75	20	patients	patient	NOUN
aiua-10978	75	21	treated	treat	VERB
aiua-10978	75	22	with	with	ADP
aiua-10978	75	23	propiverine	propiverine	ADJ
aiua-10978	75	24	(	(	PUNCT
aiua-10978	75	25	12	12	NUM
aiua-10978	75	26	)	)	PUNCT
aiua-10978	75	27	.	.	PUNCT
aiua-10978	76	1	also	also	ADV
aiua-10978	76	2	,	,	PUNCT
aiua-10978	76	3	khullar	khullar	ADJ
aiua-10978	76	4	et	et	PROPN
aiua-10978	76	5	al	al	PROPN
aiua-10978	76	6	.	.	PROPN
aiua-10978	76	7	reported	report	VERB
aiua-10978	76	8	that	that	SCONJ
aiua-10978	76	9	a	a	DET
aiua-10978	76	10	pvr	pvr	NOUN
aiua-10978	76	11	exceeding	exceed	VERB
aiua-10978	76	12	300	300	NUM
aiua-10978	76	13	ml	ml	NOUN
aiua-10978	76	14	was	be	AUX
aiua-10978	76	15	seen	see	VERB
aiua-10978	76	16	in	in	ADP
aiua-10978	76	17	0.2	0.2	NUM
aiua-10978	76	18	%	%	NOUN
aiua-10978	76	19	of	of	ADP
aiua-10978	76	20	patients	patient	NOUN
aiua-10978	76	21	treated	treat	VERB
aiua-10978	76	22	with	with	ADP
aiua-10978	76	23	β3	β3	ADJ
aiua-10978	76	24	adrenergic	adrenergic	ADJ
aiua-10978	76	25	agonists	agonist	NOUN
aiua-10978	76	26	(	(	PUNCT
aiua-10978	76	27	7	7	NUM
aiua-10978	76	28	)	)	PUNCT
aiua-10978	76	29	.	.	PUNCT
aiua-10978	77	1	these	these	DET
aiua-10978	77	2	studies	study	NOUN
aiua-10978	77	3	suggest	suggest	VERB
aiua-10978	77	4	that	that	SCONJ
aiua-10978	77	5	the	the	DET
aiua-10978	77	6	pvr	pvr	NOUN
aiua-10978	77	7	is	be	AUX
aiua-10978	77	8	not	not	PART
aiua-10978	77	9	a	a	DET
aiua-10978	77	10	determining	determine	VERB
aiua-10978	77	11	criterion	criterion	NOUN
aiua-10978	77	12	during	during	ADP
aiua-10978	77	13	the	the	DET
aiua-10978	77	14	selection	selection	NOUN
aiua-10978	77	15	of	of	ADP
aiua-10978	77	16	anticholinergic	anticholinergic	ADJ
aiua-10978	77	17	drugs	drug	NOUN
aiua-10978	77	18	or	or	CCONJ
aiua-10978	77	19	β3	β3	VERB
aiua-10978	77	20	adrenergic	adrenergic	ADJ
aiua-10978	77	21	agonists	agonist	NOUN
aiua-10978	77	22	.	.	PUNCT
aiua-10978	78	1	regarding	regard	VERB
aiua-10978	78	2	the	the	DET
aiua-10978	78	3	frequency	frequency	NOUN
aiua-10978	78	4	of	of	ADP
aiua-10978	78	5	urinary	urinary	ADJ
aiua-10978	78	6	retention	retention	NOUN
aiua-10978	78	7	,	,	PUNCT
aiua-10978	78	8	it	it	PRON
aiua-10978	78	9	has	have	AUX
aiua-10978	78	10	been	be	AUX
aiua-10978	78	11	reported	report	VERB
aiua-10978	78	12	that	that	SCONJ
aiua-10978	78	13	it	it	PRON
aiua-10978	78	14	was	be	AUX
aiua-10978	78	15	<	<	X
aiua-10978	78	16	1	1	NUM
aiua-10978	78	17	%	%	NOUN
aiua-10978	78	18	in	in	ADP
aiua-10978	78	19	patients	patient	NOUN
aiua-10978	78	20	treated	treat	VERB
aiua-10978	78	21	with	with	ADP
aiua-10978	78	22	anticholinergic	anticholinergic	ADJ
aiua-10978	78	23	drugs	drug	NOUN
aiua-10978	78	24	,	,	PUNCT
aiua-10978	78	25	while	while	SCONJ
aiua-10978	78	26	it	it	PRON
aiua-10978	78	27	was	be	AUX
aiua-10978	78	28	almost	almost	ADV
aiua-10978	78	29	negligible	negligible	ADJ
aiua-10978	78	30	in	in	ADP
aiua-10978	78	31	patients	patient	NOUN
aiua-10978	78	32	treated	treat	VERB
aiua-10978	78	33	with	with	ADP
aiua-10978	78	34	β3	β3	ADJ
aiua-10978	78	35	adrenergic	adrenergic	ADJ
aiua-10978	78	36	agonists	agonist	NOUN
aiua-10978	78	37	(	(	PUNCT
aiua-10978	78	38	13	13	NUM
aiua-10978	78	39	)	)	PUNCT
aiua-10978	78	40	.	.	PUNCT
aiua-10978	79	1	in	in	ADP
aiua-10978	79	2	the	the	DET
aiua-10978	79	3	present	present	ADJ
aiua-10978	79	4	study	study	NOUN
aiua-10978	79	5	the	the	DET
aiua-10978	79	6	pretreatment	pretreatment	NOUN
aiua-10978	79	7	pvr	pvr	NOUN
aiua-10978	79	8	was	be	AUX
aiua-10978	79	9	significantly	significantly	ADV
aiua-10978	79	10	higher	high	ADJ
aiua-10978	79	11	in	in	ADP
aiua-10978	79	12	patients	patient	NOUN
aiua-10978	79	13	who	who	PRON
aiua-10978	79	14	were	be	AUX
aiua-10978	79	15	prescribed	prescribe	VERB
aiua-10978	79	16	anticholinergics	anticholinergic	NOUN
aiua-10978	79	17	compared	compare	VERB
aiua-10978	79	18	to	to	ADP
aiua-10978	79	19	those	those	PRON
aiua-10978	79	20	who	who	PRON
aiua-10978	79	21	were	be	AUX
aiua-10978	79	22	treated	treat	VERB
aiua-10978	79	23	with	with	ADP
aiua-10978	79	24	β3	β3	ADJ
aiua-10978	79	25	adrenergic	adrenergic	ADJ
aiua-10978	79	26	agonists	agonist	NOUN
aiua-10978	79	27	,	,	PUNCT
aiua-10978	79	28	but	but	CCONJ
aiua-10978	79	29	this	this	DET
aiua-10978	79	30	finding	finding	NOUN
aiua-10978	79	31	seemed	seem	VERB
aiua-10978	79	32	to	to	PART
aiua-10978	79	33	be	be	AUX
aiua-10978	79	34	of	of	ADP
aiua-10978	79	35	limited	limited	ADJ
aiua-10978	79	36	clinical	clinical	ADJ
aiua-10978	79	37	significance	significance	NOUN
aiua-10978	79	38	because	because	SCONJ
aiua-10978	79	39	it	it	PRON
aiua-10978	79	40	was	be	AUX
aiua-10978	79	41	related	relate	VERB
aiua-10978	79	42	to	to	ADP
aiua-10978	79	43	only	only	ADV
aiua-10978	79	44	three	three	NUM
aiua-10978	79	45	patients	patient	NOUN
aiua-10978	79	46	with	with	ADP
aiua-10978	79	47	high	high	ADJ
aiua-10978	79	48	pvr	pvr	NOUN
aiua-10978	79	49	taking	take	VERB
aiua-10978	79	50	anticholinergics	anticholinergic	NOUN
aiua-10978	79	51	.	.	PUNCT
aiua-10978	80	1	compliance	compliance	NOUN
aiua-10978	80	2	to	to	ADP
aiua-10978	80	3	treatment	treatment	NOUN
aiua-10978	80	4	it	it	PRON
aiua-10978	80	5	has	have	AUX
aiua-10978	80	6	been	be	AUX
aiua-10978	80	7	reported	report	VERB
aiua-10978	80	8	that	that	SCONJ
aiua-10978	80	9	the	the	DET
aiua-10978	80	10	1	1	NUM
aiua-10978	80	11	-	-	PUNCT
aiua-10978	80	12	year	year	NOUN
aiua-10978	80	13	persistence	persistence	NOUN
aiua-10978	80	14	rates	rate	NOUN
aiua-10978	80	15	of	of	ADP
aiua-10978	80	16	anticholinergic	anticholinergic	ADJ
aiua-10978	80	17	drugs	drug	NOUN
aiua-10978	80	18	and	and	CCONJ
aiua-10978	80	19	mirabegron	mirabegron	PROPN
aiua-10978	80	20	ranged	range	VERB
aiua-10978	80	21	from	from	ADP
aiua-10978	80	22	17	17	NUM
aiua-10978	80	23	%	%	NOUN
aiua-10978	80	24	to	to	PART
aiua-10978	80	25	35	35	NUM
aiua-10978	80	26	%	%	NOUN
aiua-10978	80	27	(	(	PUNCT
aiua-10978	80	28	14	14	NUM
aiua-10978	80	29	)	)	PUNCT
aiua-10978	80	30	and	and	CCONJ
aiua-10978	80	31	19	19	NUM
aiua-10978	80	32	-	-	SYM
aiua-10978	80	33	38	38	NUM
aiua-10978	80	34	%	%	NOUN
aiua-10978	80	35	(	(	PUNCT
aiua-10978	80	36	9	9	NUM
aiua-10978	80	37	,	,	PUNCT
aiua-10978	80	38	15	15	NUM
aiua-10978	80	39	,	,	PUNCT
aiua-10978	80	40	16	16	NUM
aiua-10978	80	41	)	)	PUNCT
aiua-10978	80	42	,	,	PUNCT
aiua-10978	80	43	respectively	respectively	ADV
aiua-10978	80	44	.	.	PUNCT
aiua-10978	81	1	the	the	DET
aiua-10978	81	2	1	1	NUM
aiua-10978	81	3	-	-	PUNCT
aiua-10978	81	4	year	year	NOUN
aiua-10978	81	5	persistence	persistence	NOUN
aiua-10978	81	6	rates	rate	NOUN
aiua-10978	81	7	of	of	ADP
aiua-10978	81	8	anticholinergic	anticholinergic	ADJ
aiua-10978	81	9	drugs	drug	NOUN
aiua-10978	81	10	and	and	CCONJ
aiua-10978	81	11	β3	β3	VERB
aiua-10978	81	12	adrenergic	adrenergic	ADJ
aiua-10978	81	13	agonists	agonist	NOUN
aiua-10978	81	14	at	at	ADP
aiua-10978	81	15	our	our	PRON
aiua-10978	81	16	institution	institution	NOUN
aiua-10978	81	17	were	be	AUX
aiua-10978	81	18	similar	similar	ADJ
aiua-10978	81	19	.	.	PUNCT
aiua-10978	82	1	it	it	PRON
aiua-10978	82	2	has	have	AUX
aiua-10978	82	3	been	be	AUX
aiua-10978	82	4	reported	report	VERB
aiua-10978	82	5	that	that	SCONJ
aiua-10978	82	6	treatment	treatment	NOUN
aiua-10978	82	7	discontinuation	discontinuation	NOUN
aiua-10978	82	8	is	be	AUX
aiua-10978	82	9	also	also	ADV
aiua-10978	82	10	seen	see	VERB
aiua-10978	82	11	in	in	ADP
aiua-10978	82	12	younger	young	ADJ
aiua-10978	82	13	age	age	NOUN
aiua-10978	82	14	groups	group	NOUN
aiua-10978	82	15	,	,	PUNCT
aiua-10978	82	16	and	and	CCONJ
aiua-10978	82	17	our	our	PRON
aiua-10978	82	18	study	study	NOUN
aiua-10978	82	19	showed	show	VERB
aiua-10978	82	20	a	a	DET
aiua-10978	82	21	similar	similar	ADJ
aiua-10978	82	22	trend	trend	NOUN
aiua-10978	82	23	(	(	PUNCT
aiua-10978	82	24	17	17	NUM
aiua-10978	82	25	)	)	PUNCT
aiua-10978	82	26	.	.	PUNCT
aiua-10978	83	1	we	we	PRON
aiua-10978	83	2	suggest	suggest	VERB
aiua-10978	83	3	that	that	SCONJ
aiua-10978	83	4	this	this	PRON
aiua-10978	83	5	could	could	AUX
aiua-10978	83	6	be	be	AUX
aiua-10978	83	7	explained	explain	VERB
aiua-10978	83	8	by	by	ADP
aiua-10978	83	9	the	the	DET
aiua-10978	83	10	fact	fact	NOUN
aiua-10978	83	11	that	that	SCONJ
aiua-10978	83	12	the	the	DET
aiua-10978	83	13	drugs	drug	NOUN
aiua-10978	83	14	were	be	AUX
aiua-10978	83	15	administered	administer	VERB
aiua-10978	83	16	at	at	ADP
aiua-10978	83	17	hospital	hospital	NOUN
aiua-10978	83	18	,	,	PUNCT
aiua-10978	83	19	and	and	CCONJ
aiua-10978	83	20	an	an	DET
aiua-10978	83	21	appointment	appointment	NOUN
aiua-10978	83	22	was	be	AUX
aiua-10978	83	23	required	require	VERB
aiua-10978	83	24	to	to	PART
aiua-10978	83	25	visit	visit	VERB
aiua-10978	83	26	the	the	DET
aiua-10978	83	27	hospital	hospital	NOUN
aiua-10978	83	28	.	.	PUNCT
aiua-10978	84	1	however	however	ADV
aiua-10978	84	2	,	,	PUNCT
aiua-10978	84	3	a	a	DET
aiua-10978	84	4	recent	recent	ADJ
aiua-10978	84	5	study	study	NOUN
aiua-10978	84	6	suggested	suggest	VERB
aiua-10978	84	7	that	that	SCONJ
aiua-10978	84	8	β3	β3	VERB
aiua-10978	84	9	adrenergic	adrenergic	ADJ
aiua-10978	84	10	agonists	agonist	NOUN
aiua-10978	84	11	have	have	VERB
aiua-10978	84	12	very	very	ADV
aiua-10978	84	13	high	high	ADJ
aiua-10978	84	14	1	1	NUM
aiua-10978	84	15	-	-	PUNCT
aiua-10978	84	16	year	year	NOUN
aiua-10978	84	17	persistence	persistence	NOUN
aiua-10978	84	18	rates	rate	NOUN
aiua-10978	84	19	of	of	ADP
aiua-10978	84	20	63	63	NUM
aiua-10978	84	21	%	%	NOUN
aiua-10978	84	22	in	in	ADP
aiua-10978	84	23	females	female	NOUN
aiua-10978	84	24	and	and	CCONJ
aiua-10978	84	25	67	67	NUM
aiua-10978	84	26	%	%	NOUN
aiua-10978	84	27	in	in	ADP
aiua-10978	84	28	males	male	NOUN
aiua-10978	84	29	(	(	PUNCT
aiua-10978	84	30	18	18	NUM
aiua-10978	84	31	)	)	PUNCT
aiua-10978	84	32	.	.	PUNCT
aiua-10978	85	1	it	it	PRON
aiua-10978	85	2	was	be	AUX
aiua-10978	85	3	considered	consider	VERB
aiua-10978	85	4	that	that	SCONJ
aiua-10978	85	5	this	this	PRON
aiua-10978	85	6	was	be	AUX
aiua-10978	85	7	probably	probably	ADV
aiua-10978	85	8	because	because	SCONJ
aiua-10978	85	9	β3	β3	VERB
aiua-10978	85	10	adrenergic	adrenergic	ADJ
aiua-10978	85	11	agonists	agonist	NOUN
aiua-10978	85	12	are	be	AUX
aiua-10978	85	13	safe	safe	ADJ
aiua-10978	85	14	and	and	CCONJ
aiua-10978	85	15	well	well	ADV
aiua-10978	85	16	tolerated	tolerate	VERB
aiua-10978	85	17	.	.	PUNCT
aiua-10978	86	1	non	non	ADJ
aiua-10978	86	2	-	-	ADJ
aiua-10978	86	3	medical	medical	ADJ
aiua-10978	86	4	factors	factor	NOUN
aiua-10978	86	5	recently	recently	ADV
aiua-10978	86	6	,	,	PUNCT
aiua-10978	86	7	a	a	DET
aiua-10978	86	8	study	study	NOUN
aiua-10978	86	9	reported	report	VERB
aiua-10978	86	10	that	that	SCONJ
aiua-10978	86	11	when	when	SCONJ
aiua-10978	86	12	physicians	physician	NOUN
aiua-10978	86	13	received	receive	VERB
aiua-10978	86	14	complimentary	complimentary	ADJ
aiua-10978	86	15	meals	meal	NOUN
aiua-10978	86	16	and	and	CCONJ
aiua-10978	86	17	hospitality	hospitality	NOUN
aiua-10978	86	18	by	by	ADP
aiua-10978	86	19	a	a	DET
aiua-10978	86	20	pharmaceutical	pharmaceutical	ADJ
aiua-10978	86	21	company	company	NOUN
aiua-10978	86	22	they	they	PRON
aiua-10978	86	23	increased	increase	VERB
aiua-10978	86	24	their	their	PRON
aiua-10978	86	25	prescriptions	prescription	NOUN
aiua-10978	86	26	of	of	ADP
aiua-10978	86	27	drugs	drug	NOUN
aiua-10978	86	28	marketed	market	VERB
aiua-10978	86	29	by	by	ADP
aiua-10978	86	30	that	that	DET
aiua-10978	86	31	company	company	NOUN
aiua-10978	86	32	(	(	PUNCT
aiua-10978	86	33	19	19	NUM
aiua-10978	86	34	)	)	PUNCT
aiua-10978	86	35	.	.	PUNCT
aiua-10978	87	1	although	although	SCONJ
aiua-10978	87	2	this	this	PRON
aiua-10978	87	3	may	may	AUX
aiua-10978	87	4	have	have	AUX
aiua-10978	87	5	affected	affect	VERB
aiua-10978	87	6	our	our	PRON
aiua-10978	87	7	prescription	prescription	NOUN
aiua-10978	87	8	patterns	pattern	NOUN
aiua-10978	87	9	,	,	PUNCT
aiua-10978	87	10	we	we	PRON
aiua-10978	87	11	do	do	AUX
aiua-10978	87	12	not	not	PART
aiua-10978	87	13	have	have	VERB
aiua-10978	87	14	any	any	DET
aiua-10978	87	15	information	information	NOUN
aiua-10978	87	16	about	about	ADP
aiua-10978	87	17	this	this	PRON
aiua-10978	87	18	in	in	ADP
aiua-10978	87	19	the	the	DET
aiua-10978	87	20	present	present	ADJ
aiua-10978	87	21	study	study	NOUN
aiua-10978	87	22	.	.	PUNCT
aiua-10978	88	1	this	this	PRON
aiua-10978	88	2	could	could	AUX
aiua-10978	88	3	be	be	AUX
aiua-10978	88	4	an	an	DET
aiua-10978	88	5	important	important	ADJ
aiua-10978	88	6	subject	subject	NOUN
aiua-10978	88	7	for	for	ADP
aiua-10978	88	8	further	further	ADJ
aiua-10978	88	9	study	study	NOUN
aiua-10978	88	10	,	,	PUNCT
aiua-10978	88	11	including	include	VERB
aiua-10978	88	12	other	other	ADJ
aiua-10978	88	13	oral	oral	ADJ
aiua-10978	88	14	medications	medication	NOUN
aiua-10978	88	15	.	.	PUNCT
aiua-10978	89	1	limitations	limitation	NOUN
aiua-10978	89	2	our	our	PRON
aiua-10978	89	3	study	study	NOUN
aiua-10978	89	4	presented	present	VERB
aiua-10978	89	5	some	some	DET
aiua-10978	89	6	limitations	limitation	NOUN
aiua-10978	89	7	:	:	PUNCT
aiua-10978	89	8	1	1	X
aiua-10978	89	9	)	)	PUNCT
aiua-10978	89	10	it	it	PRON
aiua-10978	89	11	was	be	AUX
aiua-10978	89	12	a	a	DET
aiua-10978	89	13	retrospective	retrospective	ADJ
aiua-10978	89	14	cohort	cohort	NOUN
aiua-10978	89	15	study	study	NOUN
aiua-10978	89	16	,	,	PUNCT
aiua-10978	89	17	which	which	PRON
aiua-10978	89	18	involved	involve	VERB
aiua-10978	89	19	the	the	DET
aiua-10978	89	20	extraction	extraction	NOUN
aiua-10978	89	21	of	of	ADP
aiua-10978	89	22	electronically	electronically	ADV
aiua-10978	89	23	stored	store	VERB
aiua-10978	89	24	clinical	clinical	ADJ
aiua-10978	89	25	data	datum	NOUN
aiua-10978	89	26	,	,	PUNCT
aiua-10978	89	27	and	and	CCONJ
aiua-10978	89	28	it	it	PRON
aiua-10978	89	29	had	have	VERB
aiua-10978	89	30	a	a	DET
aiua-10978	89	31	small	small	ADJ
aiua-10978	89	32	sample	sample	NOUN
aiua-10978	89	33	size	size	NOUN
aiua-10978	89	34	.	.	PUNCT
aiua-10978	90	1	thus	thus	ADV
aiua-10978	90	2	,	,	PUNCT
aiua-10978	90	3	it	it	PRON
aiua-10978	90	4	will	will	AUX
aiua-10978	90	5	be	be	AUX
aiua-10978	90	6	necessary	necessary	ADJ
aiua-10978	90	7	to	to	PART
aiua-10978	90	8	validate	validate	VERB
aiua-10978	90	9	the	the	DET
aiua-10978	90	10	findings	finding	NOUN
aiua-10978	90	11	of	of	ADP
aiua-10978	90	12	this	this	DET
aiua-10978	90	13	retrospective	retrospective	ADJ
aiua-10978	90	14	analysis	analysis	NOUN
aiua-10978	90	15	in	in	ADP
aiua-10978	90	16	prospective	prospective	ADJ
aiua-10978	90	17	studies	study	NOUN
aiua-10978	90	18	,	,	PUNCT
aiua-10978	90	19	including	include	VERB
aiua-10978	90	20	a	a	DET
aiua-10978	90	21	randomized	randomized	ADJ
aiua-10978	90	22	study	study	NOUN
aiua-10978	90	23	,	,	PUNCT
aiua-10978	90	24	with	with	ADP
aiua-10978	90	25	larger	large	ADJ
aiua-10978	90	26	populations	population	NOUN
aiua-10978	90	27	in	in	ADP
aiua-10978	90	28	future	future	NOUN
aiua-10978	90	29	.	.	PUNCT
aiua-10978	91	1	we	we	PRON
aiua-10978	91	2	expect	expect	VERB
aiua-10978	91	3	that	that	SCONJ
aiua-10978	91	4	such	such	ADJ
aiua-10978	91	5	studies	study	NOUN
aiua-10978	91	6	will	will	AUX
aiua-10978	91	7	provide	provide	VERB
aiua-10978	91	8	new	new	ADJ
aiua-10978	91	9	perspectives	perspective	NOUN
aiua-10978	91	10	on	on	ADP
aiua-10978	91	11	how	how	SCONJ
aiua-10978	91	12	decisions	decision	NOUN
aiua-10978	91	13	regarding	regard	VERB
aiua-10978	91	14	the	the	DET
aiua-10978	91	15	selection	selection	NOUN
aiua-10978	91	16	of	of	ADP
aiua-10978	91	17	anticholinergic	anticholinergic	ADJ
aiua-10978	91	18	drugs	drug	NOUN
aiua-10978	91	19	and	and	CCONJ
aiua-10978	91	20	β3	β3	VERB
aiua-10978	91	21	adrenergic	adrenergic	ADJ
aiua-10978	91	22	agonists	agonist	NOUN
aiua-10978	91	23	are	be	AUX
aiua-10978	91	24	made	make	VERB
aiua-10978	91	25	.	.	PUNCT
aiua-10978	92	1	2	2	NUM
aiua-10978	92	2	)	)	PUNCT
aiua-10978	92	3	since	since	SCONJ
aiua-10978	92	4	this	this	DET
aiua-10978	92	5	study	study	NOUN
aiua-10978	92	6	only	only	ADV
aiua-10978	92	7	involved	involve	VERB
aiua-10978	92	8	females	female	NOUN
aiua-10978	92	9	,	,	PUNCT
aiua-10978	92	10	the	the	DET
aiua-10978	92	11	factors	factor	NOUN
aiua-10978	92	12	influencing	influence	VERB
aiua-10978	92	13	the	the	DET
aiua-10978	92	14	selection	selection	NOUN
aiua-10978	92	15	of	of	ADP
aiua-10978	92	16	anticholinergic	anticholinergic	ADJ
aiua-10978	92	17	drugs	drug	NOUN
aiua-10978	92	18	or	or	CCONJ
aiua-10978	92	19	β3	β3	VERB
aiua-10978	92	20	adrenergic	adrenergic	ADJ
aiua-10978	92	21	agonists	agonist	NOUN
aiua-10978	92	22	in	in	ADP
aiua-10978	92	23	male	male	ADJ
aiua-10978	92	24	oab	oab	PROPN
aiua-10978	92	25	patients	patient	NOUN
aiua-10978	92	26	were	be	AUX
aiua-10978	92	27	not	not	PART
aiua-10978	92	28	evaluated	evaluate	VERB
aiua-10978	92	29	.	.	PUNCT
aiua-10978	93	1	3	3	X
aiua-10978	93	2	)	)	PUNCT
aiua-10978	93	3	the	the	DET
aiua-10978	93	4	patients	patient	NOUN
aiua-10978	93	5	’	’	PART
aiua-10978	93	6	complications	complication	NOUN
aiua-10978	93	7	and	and	CCONJ
aiua-10978	93	8	the	the	DET
aiua-10978	93	9	other	other	ADJ
aiua-10978	93	10	types	type	NOUN
aiua-10978	93	11	of	of	ADP
aiua-10978	93	12	medications	medication	NOUN
aiua-10978	93	13	they	they	PRON
aiua-10978	93	14	were	be	AUX
aiua-10978	93	15	taking	take	VERB
aiua-10978	93	16	were	be	AUX
aiua-10978	93	17	not	not	PART
aiua-10978	93	18	investigated	investigate	VERB
aiua-10978	93	19	,	,	PUNCT
aiua-10978	93	20	and	and	CCONJ
aiua-10978	93	21	hence	hence	ADV
aiua-10978	93	22	,	,	PUNCT
aiua-10978	93	23	more	more	ADV
aiua-10978	93	24	detailed	detailed	ADJ
aiua-10978	93	25	patient	patient	ADJ
aiua-10978	93	26	background	background	NOUN
aiua-10978	93	27	information	information	NOUN
aiua-10978	93	28	is	be	AUX
aiua-10978	93	29	needed	need	VERB
aiua-10978	93	30	.	.	PUNCT
aiua-10978	94	1	4	4	X
aiua-10978	94	2	)	)	PUNCT
aiua-10978	94	3	the	the	DET
aiua-10978	94	4	two	two	NUM
aiua-10978	94	5	-	-	PUNCT
aiua-10978	94	6	year	year	NOUN
aiua-10978	94	7	observation	observation	NOUN
aiua-10978	94	8	period	period	NOUN
aiua-10978	94	9	was	be	AUX
aiua-10978	94	10	relatively	relatively	ADV
aiua-10978	94	11	short	short	ADJ
aiua-10978	94	12	,	,	PUNCT
aiua-10978	94	13	archivio	archivio	NOUN
aiua-10978	94	14	italiano	italiano	NOUN
aiua-10978	94	15	di	di	X
aiua-10978	94	16	urologia	urologia	PROPN
aiua-10978	94	17	e	e	PROPN
aiua-10978	94	18	andrologia	andrologia	PROPN
aiua-10978	94	19	2022	2022	NUM
aiua-10978	94	20	;	;	PUNCT
aiua-10978	94	21	94	94	NUM
aiua-10978	94	22	,	,	PUNCT
aiua-10978	94	23	4	4	NUM
aiua-10978	94	24	h.	h.	PROPN
aiua-10978	94	25	masuda	masuda	PROPN
aiua-10978	94	26	,	,	PUNCT
aiua-10978	94	27	k.	k.	PROPN
aiua-10978	94	28	mikami	mikami	PROPN
aiua-10978	94	29	,	,	PUNCT
aiua-10978	94	30	k.	k.	PROPN
aiua-10978	94	31	otsuka	otsuka	PROPN
aiua-10978	94	32	,	,	PUNCT
aiua-10978	94	33	k.	k.	PROPN
aiua-10978	94	34	hou	hou	PROPN
aiua-10978	94	35	,	,	PUNCT
aiua-10978	94	36	t.	t.	NOUN
aiua-10978	94	37	suyama	suyama	NOUN
aiua-10978	94	38	,	,	PUNCT
aiua-10978	94	39	k.	k.	PROPN
aiua-10978	94	40	araki	araki	PROPN
aiua-10978	94	41	,	,	PUNCT
aiua-10978	94	42	s.	s.	PROPN
aiua-10978	94	43	kojima	kojima	PROPN
aiua-10978	94	44	,	,	PUNCT
aiua-10978	94	45	y.	y.	PROPN
aiua-10978	94	46	naya	naya	PROPN
aiua-10978	94	47	454	454	NUM
aiua-10978	94	48	and	and	CCONJ
aiua-10978	94	49	hence	hence	ADV
aiua-10978	94	50	,	,	PUNCT
aiua-10978	94	51	it	it	PRON
aiua-10978	94	52	may	may	AUX
aiua-10978	94	53	not	not	PART
aiua-10978	94	54	have	have	AUX
aiua-10978	94	55	been	be	AUX
aiua-10978	94	56	long	long	ADV
aiua-10978	94	57	enough	enough	ADV
aiua-10978	94	58	to	to	PART
aiua-10978	94	59	allow	allow	VERB
aiua-10978	94	60	appropriate	appropriate	ADJ
aiua-10978	94	61	evaluations	evaluation	NOUN
aiua-10978	94	62	to	to	PART
aiua-10978	94	63	be	be	AUX
aiua-10978	94	64	performed	perform	VERB
aiua-10978	94	65	.	.	PUNCT
aiua-10978	95	1	5	5	X
aiua-10978	95	2	)	)	PUNCT
aiua-10978	95	3	patients	patient	NOUN
aiua-10978	95	4	assuming	assume	VERB
aiua-10978	95	5	anticholinergics	anticholinergic	NOUN
aiua-10978	95	6	were	be	AUX
aiua-10978	95	7	analyzed	analyze	VERB
aiua-10978	95	8	collectively	collectively	ADV
aiua-10978	95	9	because	because	SCONJ
aiua-10978	95	10	the	the	DET
aiua-10978	95	11	small	small	ADJ
aiua-10978	95	12	number	number	NOUN
aiua-10978	95	13	of	of	ADP
aiua-10978	95	14	patients	patient	NOUN
aiua-10978	95	15	taking	take	VERB
aiua-10978	95	16	different	different	ADJ
aiua-10978	95	17	anticholinergics	anticholinergic	NOUN
aiua-10978	95	18	did	do	AUX
aiua-10978	95	19	not	not	PART
aiua-10978	95	20	allow	allow	VERB
aiua-10978	95	21	to	to	PART
aiua-10978	95	22	analyze	analyze	VERB
aiua-10978	95	23	them	they	PRON
aiua-10978	95	24	separately	separately	ADV
aiua-10978	95	25	.	.	PUNCT
aiua-10978	96	1	collection	collection	NOUN
aiua-10978	96	2	of	of	ADP
aiua-10978	96	3	larger	large	ADJ
aiua-10978	96	4	populations	population	NOUN
aiua-10978	96	5	taking	take	VERB
aiua-10978	96	6	different	different	ADJ
aiua-10978	96	7	anticholinergics	anticholinergic	NOUN
aiua-10978	96	8	could	could	AUX
aiua-10978	96	9	give	give	VERB
aiua-10978	96	10	information	information	NOUN
aiua-10978	96	11	about	about	ADP
aiua-10978	96	12	difference	difference	NOUN
aiua-10978	96	13	of	of	ADP
aiua-10978	96	14	outcomes	outcome	NOUN
aiua-10978	96	15	between	between	ADP
aiua-10978	96	16	them	they	PRON
aiua-10978	96	17	.	.	PUNCT
aiua-10978	97	1	6	6	NUM
aiua-10978	97	2	)	)	PUNCT
aiua-10978	97	3	untreated	untreated	ADJ
aiua-10978	97	4	patients	patient	NOUN
aiua-10978	97	5	were	be	AUX
aiua-10978	97	6	not	not	PART
aiua-10978	97	7	investigated	investigate	VERB
aiua-10978	97	8	.	.	PUNCT
aiua-10978	98	1	7	7	X
aiua-10978	98	2	)	)	PUNCT
aiua-10978	98	3	we	we	PRON
aiua-10978	98	4	did	do	AUX
aiua-10978	98	5	not	not	PART
aiua-10978	98	6	investigate	investigate	VERB
aiua-10978	98	7	refractory	refractory	NOUN
aiua-10978	98	8	oab	oab	PROPN
aiua-10978	98	9	separately	separately	ADV
aiua-10978	98	10	.	.	PUNCT
aiua-10978	99	1	conclusions	conclusion	NOUN
aiua-10978	99	2	there	there	PRON
aiua-10978	99	3	were	be	VERB
aiua-10978	99	4	no	no	DET
aiua-10978	99	5	significant	significant	ADJ
aiua-10978	99	6	differences	difference	NOUN
aiua-10978	99	7	in	in	ADP
aiua-10978	99	8	clinical	clinical	ADJ
aiua-10978	99	9	characteristics	characteristic	NOUN
aiua-10978	99	10	of	of	ADP
aiua-10978	99	11	patients	patient	NOUN
aiua-10978	99	12	who	who	PRON
aiua-10978	99	13	were	be	AUX
aiua-10978	99	14	prescribed	prescribe	VERB
aiua-10978	99	15	anticholinergics	anticholinergic	NOUN
aiua-10978	99	16	and	and	CCONJ
aiua-10978	99	17	β3	β3	VERB
aiua-10978	99	18	adrenergic	adrenergic	ADJ
aiua-10978	99	19	agonists	agonist	NOUN
aiua-10978	99	20	for	for	ADP
aiua-10978	99	21	oab	oab	PROPN
aiua-10978	99	22	treatment	treatment	NOUN
aiua-10978	99	23	,	,	PUNCT
aiua-10978	99	24	but	but	CCONJ
aiua-10978	99	25	a	a	DET
aiua-10978	99	26	marginal	marginal	ADJ
aiua-10978	99	27	difference	difference	NOUN
aiua-10978	99	28	of	of	ADP
aiua-10978	99	29	pvr	pvr	NOUN
aiua-10978	99	30	value	value	NOUN
aiua-10978	99	31	before	before	ADP
aiua-10978	99	32	treatment	treatment	NOUN
aiua-10978	99	33	.	.	PUNCT
aiua-10978	100	1	the	the	DET
aiua-10978	100	2	1	1	NUM
aiua-10978	100	3	-	-	PUNCT
aiua-10978	100	4	year	year	NOUN
aiua-10978	100	5	persistence	persistence	NOUN
aiua-10978	100	6	rates	rate	NOUN
aiua-10978	100	7	of	of	ADP
aiua-10978	100	8	anticholinergic	anticholinergic	ADJ
aiua-10978	100	9	drugs	drug	NOUN
aiua-10978	100	10	and	and	CCONJ
aiua-10978	100	11	β3	β3	VERB
aiua-10978	100	12	adrenergic	adrenergic	ADJ
aiua-10978	100	13	agonists	agonist	NOUN
aiua-10978	100	14	were	be	AUX
aiua-10978	100	15	considered	consider	VERB
aiua-10978	100	16	to	to	PART
aiua-10978	100	17	be	be	AUX
aiua-10978	100	18	almost	almost	ADV
aiua-10978	100	19	equivalent	equivalent	ADJ
aiua-10978	100	20	.	.	PUNCT
aiua-10978	101	1	references	reference	NOUN
aiua-10978	101	2	1	1	NUM
aiua-10978	101	3	.	.	PUNCT
aiua-10978	101	4	abrams	abrams	PROPN
aiua-10978	101	5	p	p	PROPN
aiua-10978	101	6	,	,	PUNCT
aiua-10978	101	7	cardozo	cardozo	PROPN
aiua-10978	101	8	l	l	PROPN
aiua-10978	101	9	,	,	PUNCT
aiua-10978	101	10	fall	fall	VERB
aiua-10978	101	11	m	m	PROPN
aiua-10978	101	12	paul	paul	PROPN
aiua-10978	101	13	abrams	abrams	PROPN
aiua-10978	101	14	,	,	PUNCT
aiua-10978	101	15	et	et	PROPN
aiua-10978	101	16	al	al	PROPN
aiua-10978	101	17	.	.	PUNCT
aiua-10978	102	1	the	the	DET
aiua-10978	102	2	standardisation	standardisation	NOUN
aiua-10978	102	3	of	of	ADP
aiua-10978	102	4	terminology	terminology	NOUN
aiua-10978	102	5	of	of	ADP
aiua-10978	102	6	lower	low	ADJ
aiua-10978	102	7	urinary	urinary	ADJ
aiua-10978	102	8	tract	tract	NOUN
aiua-10978	102	9	function	function	NOUN
aiua-10978	102	10	:	:	PUNCT
aiua-10978	102	11	report	report	NOUN
aiua-10978	102	12	from	from	ADP
aiua-10978	102	13	the	the	DET
aiua-10978	102	14	standardisation	standardisation	NOUN
aiua-10978	102	15	sub	sub	NOUN
aiua-10978	102	16	-	-	NOUN
aiua-10978	102	17	committee	committee	NOUN
aiua-10978	102	18	of	of	ADP
aiua-10978	102	19	the	the	DET
aiua-10978	102	20	international	international	ADJ
aiua-10978	102	21	continence	continence	NOUN
aiua-10978	102	22	society	society	NOUN
aiua-10978	102	23	.	.	PUNCT
aiua-10978	103	1	neurourol	neurourol	PROPN
aiua-10978	103	2	urody	urody	PROPN
aiua-10978	103	3	.	.	PUNCT
aiua-10978	104	1	2002	2002	NUM
aiua-10978	104	2	;	;	PUNCT
aiua-10978	104	3	21:167	21:167	NUM
aiua-10978	104	4	-	-	SYM
aiua-10978	104	5	178	178	NUM
aiua-10978	104	6	.	.	PUNCT
aiua-10978	105	1	2	2	NUM
aiua-10978	105	2	.	.	X
aiua-10978	106	1	homma	homma	PROPN
aiua-10978	106	2	y	y	PROPN
aiua-10978	106	3	,	,	PUNCT
aiua-10978	106	4	yamaguchi	yamaguchi	PROPN
aiua-10978	106	5	o	o	PROPN
aiua-10978	106	6	,	,	PUNCT
aiua-10978	106	7	hayashi	hayashi	PROPN
aiua-10978	106	8	k.	k.	PROPN
aiua-10978	106	9	neurogenic	neurogenic	ADJ
aiua-10978	106	10	bladder	bladder	NOUN
aiua-10978	106	11	society	society	NOUN
aiua-10978	106	12	committee	committee	NOUN
aiua-10978	106	13	.	.	PUNCT
aiua-10978	107	1	an	an	DET
aiua-10978	107	2	epidemiological	epidemiological	ADJ
aiua-10978	107	3	survey	survey	NOUN
aiua-10978	107	4	of	of	ADP
aiua-10978	107	5	overactive	overactive	ADJ
aiua-10978	107	6	bladder	bladder	NOUN
aiua-10978	107	7	symptoms	symptom	NOUN
aiua-10978	107	8	in	in	ADP
aiua-10978	107	9	japan	japan	PROPN
aiua-10978	107	10	.	.	PUNCT
aiua-10978	108	1	bju	bju	PROPN
aiua-10978	108	2	int	int	PROPN
aiua-10978	108	3	.	.	PUNCT
aiua-10978	109	1	2005	2005	NUM
aiua-10978	109	2	;	;	PUNCT
aiua-10978	109	3	96:1314	96:1314	X
aiua-10978	109	4	-	-	SYM
aiua-10978	109	5	1318	1318	NUM
aiua-10978	109	6	.	.	PUNCT
aiua-10978	110	1	3	3	X
aiua-10978	110	2	.	.	X
aiua-10978	110	3	eapen	eapen	ADJ
aiua-10978	110	4	rs	rs	NOUN
aiua-10978	110	5	,	,	PUNCT
aiua-10978	110	6	radomski	radomski	PROPN
aiua-10978	110	7	sb	sb	PROPN
aiua-10978	110	8	.	.	PROPN
aiua-10978	110	9	review	review	PROPN
aiua-10978	110	10	of	of	ADP
aiua-10978	110	11	the	the	DET
aiua-10978	110	12	epidemiology	epidemiology	NOUN
aiua-10978	110	13	of	of	ADP
aiua-10978	110	14	overactive	overactive	ADJ
aiua-10978	110	15	bladder	bladder	NOUN
aiua-10978	110	16	.	.	PUNCT
aiua-10978	111	1	res	re	NOUN
aiua-10978	111	2	rep	rep	PROPN
aiua-10978	111	3	urol	urol	PROPN
aiua-10978	111	4	.	.	PROPN
aiua-10978	112	1	2016	2016	NUM
aiua-10978	112	2	;	;	PUNCT
aiua-10978	112	3	8:71	8:71	NUM
aiua-10978	112	4	-	-	SYM
aiua-10978	112	5	76	76	NUM
aiua-10978	112	6	.	.	PUNCT
aiua-10978	113	1	4	4	X
aiua-10978	113	2	.	.	X
aiua-10978	113	3	brown	brown	ADJ
aiua-10978	113	4	js	js	PROPN
aiua-10978	113	5	,	,	PUNCT
aiua-10978	113	6	mcghan	mcghan	PROPN
aiua-10978	113	7	wf	wf	PROPN
aiua-10978	113	8	,	,	PUNCT
aiua-10978	113	9	chokroverty	chokroverty	PROPN
aiua-10978	113	10	s.	s.	PROPN
aiua-10978	113	11	comorbidities	comorbiditie	NOUN
aiua-10978	113	12	associated	associate	VERB
aiua-10978	113	13	with	with	ADP
aiua-10978	113	14	overactive	overactive	ADJ
aiua-10978	113	15	bladder	bladder	NOUN
aiua-10978	113	16	.	.	PUNCT
aiua-10978	114	1	am	be	AUX
aiua-10978	114	2	j	j	PROPN
aiua-10978	114	3	manag	manag	PROPN
aiua-10978	114	4	care	care	NOUN
aiua-10978	114	5	.	.	PUNCT
aiua-10978	115	1	2000	2000	NUM
aiua-10978	115	2	;	;	PUNCT
aiua-10978	115	3	6	6	NUM
aiua-10978	115	4	:	:	PUNCT
aiua-10978	115	5	s574	s574	PROPN
aiua-10978	115	6	-	-	PUNCT
aiua-10978	115	7	579	579	NUM
aiua-10978	115	8	.	.	PUNCT
aiua-10978	116	1	5	5	NUM
aiua-10978	116	2	.	.	X
aiua-10978	116	3	subak	subak	PROPN
aiua-10978	116	4	ll	ll	PROPN
aiua-10978	116	5	,	,	PUNCT
aiua-10978	116	6	richter	richter	PROPN
aiua-10978	116	7	he	he	PRON
aiua-10978	116	8	,	,	PUNCT
aiua-10978	116	9	hunskaar	hunskaar	PROPN
aiua-10978	116	10	s.	s.	PROPN
aiua-10978	116	11	obesity	obesity	PROPN
aiua-10978	116	12	and	and	CCONJ
aiua-10978	116	13	urinary	urinary	ADJ
aiua-10978	116	14	incontinence	incontinence	NOUN
aiua-10978	116	15	:	:	PUNCT
aiua-10978	116	16	epidemiology	epidemiology	NOUN
aiua-10978	116	17	and	and	CCONJ
aiua-10978	116	18	clinical	clinical	ADJ
aiua-10978	116	19	research	research	NOUN
aiua-10978	116	20	update	update	NOUN
aiua-10978	116	21	.	.	PUNCT
aiua-10978	117	1	j	j	PROPN
aiua-10978	117	2	urol	urol	PROPN
aiua-10978	117	3	.	.	PUNCT
aiua-10978	117	4	2009	2009	NUM
aiua-10978	117	5	;	;	PUNCT
aiua-10978	117	6	182	182	NUM
aiua-10978	117	7	:	:	PUNCT
aiua-10978	117	8	s2	s2	VERB
aiua-10978	117	9	-	-	PUNCT
aiua-10978	117	10	7	7	NUM
aiua-10978	117	11	.	.	NOUN
aiua-10978	117	12	6	6	NUM
aiua-10978	117	13	.	.	PUNCT
aiua-10978	118	1	yamaguchi	yamaguchi	PROPN
aiua-10978	118	2	o	o	PROPN
aiua-10978	118	3	,	,	PUNCT
aiua-10978	118	4	nishizawa	nishizawa	PROPN
aiua-10978	118	5	o	o	NOUN
aiua-10978	118	6	,	,	PUNCT
aiua-10978	118	7	takeda	takeda	PROPN
aiua-10978	118	8	m	m	PROPN
aiua-10978	118	9	,	,	PUNCT
aiua-10978	118	10	et	et	PROPN
aiua-10978	118	11	al	al	PROPN
aiua-10978	118	12	.	.	PUNCT
aiua-10978	119	1	clinical	clinical	ADJ
aiua-10978	119	2	guidelines	guideline	NOUN
aiua-10978	119	3	for	for	ADP
aiua-10978	119	4	overactive	overactive	ADJ
aiua-10978	119	5	bladder	bladder	NOUN
aiua-10978	119	6	.	.	PUNCT
aiua-10978	120	1	int	int	NOUN
aiua-10978	120	2	j	j	PROPN
aiua-10978	120	3	urol	urol	ADP
aiua-10978	120	4	2009	2009	NUM
aiua-10978	120	5	;	;	PUNCT
aiua-10978	120	6	16:126	16:126	NUM
aiua-10978	120	7	-	-	SYM
aiua-10978	120	8	142	142	NUM
aiua-10978	120	9	.	.	PUNCT
aiua-10978	121	1	7	7	X
aiua-10978	121	2	.	.	X
aiua-10978	121	3	khullar	khullar	ADJ
aiua-10978	121	4	v	v	NOUN
aiua-10978	121	5	,	,	PUNCT
aiua-10978	121	6	amarenco	amarenco	NOUN
aiua-10978	121	7	g	g	PROPN
aiua-10978	121	8	,	,	PUNCT
aiua-10978	121	9	angulo	angulo	PROPN
aiua-10978	121	10	j	j	PROPN
aiua-10978	121	11	,	,	PUNCT
aiua-10978	121	12	et	et	PROPN
aiua-10978	121	13	al	al	PROPN
aiua-10978	121	14	.	.	PROPN
aiua-10978	121	15	efficacy	efficacy	NOUN
aiua-10978	121	16	and	and	CCONJ
aiua-10978	121	17	tolerability	tolerability	NOUN
aiua-10978	121	18	of	of	ADP
aiua-10978	121	19	mirabegron	mirabegron	PROPN
aiua-10978	121	20	,	,	PUNCT
aiua-10978	121	21	a	a	DET
aiua-10978	121	22	β	β	X
aiua-10978	121	23	(	(	PUNCT
aiua-10978	121	24	3)-adrenoceptor	3)-adrenoceptor	NUM
aiua-10978	121	25	agonist	agonist	NOUN
aiua-10978	121	26	,	,	PUNCT
aiua-10978	121	27	in	in	ADP
aiua-10978	121	28	patients	patient	NOUN
aiua-10978	121	29	with	with	ADP
aiua-10978	121	30	overactive	overactive	ADJ
aiua-10978	121	31	bladder	bladder	NOUN
aiua-10978	121	32	:	:	PUNCT
aiua-10978	121	33	results	result	NOUN
aiua-10978	121	34	from	from	ADP
aiua-10978	121	35	a	a	DET
aiua-10978	121	36	randomised	randomised	ADJ
aiua-10978	121	37	european	european	ADJ
aiua-10978	121	38	-	-	PUNCT
aiua-10978	121	39	australian	australian	ADJ
aiua-10978	121	40	phase	phase	NOUN
aiua-10978	121	41	3	3	NUM
aiua-10978	121	42	trial	trial	NOUN
aiua-10978	121	43	.	.	PUNCT
aiua-10978	122	1	eur	eur	PROPN
aiua-10978	122	2	urol	urol	PROPN
aiua-10978	122	3	.	.	PUNCT
aiua-10978	123	1	2013	2013	NUM
aiua-10978	123	2	;	;	PUNCT
aiua-10978	123	3	63:283	63:283	NUM
aiua-10978	123	4	-	-	SYM
aiua-10978	123	5	295	295	NUM
aiua-10978	123	6	.	.	PUNCT
aiua-10978	124	1	8	8	NUM
aiua-10978	124	2	.	.	PUNCT
aiua-10978	125	1	yamaguchi	yamaguchi	PROPN
aiua-10978	125	2	o	o	PROPN
aiua-10978	125	3	,	,	PUNCT
aiua-10978	125	4	marui	marui	PROPN
aiua-10978	125	5	e	e	PROPN
aiua-10978	125	6	,	,	PUNCT
aiua-10978	125	7	kakizaki	kakizaki	PROPN
aiua-10978	125	8	h	h	PROPN
aiua-10978	125	9	,	,	PUNCT
aiua-10978	125	10	et	et	PROPN
aiua-10978	125	11	al	al	PROPN
aiua-10978	125	12	.	.	PROPN
aiua-10978	125	13	phase	phase	PROPN
aiua-10978	125	14	iii	iii	PROPN
aiua-10978	125	15	,	,	PUNCT
aiua-10978	125	16	randomised	randomise	VERB
aiua-10978	125	17	,	,	PUNCT
aiua-10978	125	18	double	double	ADJ
aiua-10978	125	19	-	-	PUNCT
aiua-10978	125	20	blind	blind	ADJ
aiua-10978	125	21	,	,	PUNCT
aiua-10978	125	22	placebo	placebo	NOUN
aiua-10978	125	23	-	-	PUNCT
aiua-10978	125	24	controlled	control	VERB
aiua-10978	125	25	study	study	NOUN
aiua-10978	125	26	of	of	ADP
aiua-10978	125	27	the	the	DET
aiua-10978	125	28	β3	β3	ADJ
aiua-10978	125	29	-	-	PUNCT
aiua-10978	125	30	adrenoceptor	adrenoceptor	NOUN
aiua-10978	125	31	agonist	agonist	NOUN
aiua-10978	125	32	mirabegron	mirabegron	NOUN
aiua-10978	125	33	,	,	PUNCT
aiua-10978	125	34	50	50	NUM
aiua-10978	125	35	mg	mg	NOUN
aiua-10978	125	36	once	once	ADV
aiua-10978	125	37	daily	daily	ADV
aiua-10978	125	38	,	,	PUNCT
aiua-10978	125	39	in	in	ADP
aiua-10978	125	40	japanese	japanese	ADJ
aiua-10978	125	41	patients	patient	NOUN
aiua-10978	125	42	with	with	ADP
aiua-10978	125	43	overactive	overactive	ADJ
aiua-10978	125	44	bladder	bladder	NOUN
aiua-10978	125	45	.	.	PUNCT
aiua-10978	126	1	bju	bju	NOUN
aiua-10978	126	2	int	int	PROPN
aiua-10978	126	3	.	.	PUNCT
aiua-10978	127	1	2014	2014	NUM
aiua-10978	127	2	;	;	PUNCT
aiua-10978	128	1	113:951	113:951	PROPN
aiua-10978	128	2	-	-	SYM
aiua-10978	128	3	960	960	NUM
aiua-10978	128	4	.	.	NOUN
aiua-10978	128	5	9	9	NUM
aiua-10978	128	6	.	.	X
aiua-10978	128	7	chapple	chapple	PROPN
aiua-10978	128	8	cr	cr	PROPN
aiua-10978	128	9	,	,	PUNCT
aiua-10978	128	10	nazir	nazir	PROPN
aiua-10978	128	11	j	j	PROPN
aiua-10978	128	12	,	,	PUNCT
aiua-10978	128	13	hakimi	hakimi	PROPN
aiua-10978	128	14	z	z	PROPN
aiua-10978	128	15	,	,	PUNCT
aiua-10978	128	16	et	et	PROPN
aiua-10978	128	17	al	al	PROPN
aiua-10978	128	18	.	.	PROPN
aiua-10978	128	19	persistence	persistence	NOUN
aiua-10978	128	20	and	and	CCONJ
aiua-10978	128	21	adherence	adherence	NOUN
aiua-10978	128	22	with	with	ADP
aiua-10978	128	23	mirabegron	mirabegron	PROPN
aiua-10978	128	24	versus	versus	ADP
aiua-10978	128	25	antimuscarinic	antimuscarinic	ADJ
aiua-10978	128	26	agents	agent	NOUN
aiua-10978	128	27	in	in	ADP
aiua-10978	128	28	patients	patient	NOUN
aiua-10978	128	29	with	with	ADP
aiua-10978	128	30	overactive	overactive	ADJ
aiua-10978	128	31	bladder	bladder	NOUN
aiua-10978	128	32	:	:	PUNCT
aiua-10978	128	33	a	a	DET
aiua-10978	128	34	retrospective	retrospective	ADJ
aiua-10978	128	35	observational	observational	ADJ
aiua-10978	128	36	study	study	NOUN
aiua-10978	128	37	in	in	ADP
aiua-10978	128	38	uk	uk	PROPN
aiua-10978	128	39	clinical	clinical	ADJ
aiua-10978	128	40	practice	practice	NOUN
aiua-10978	128	41	.	.	PUNCT
aiua-10978	129	1	eur	eur	PROPN
aiua-10978	129	2	urol	urol	PROPN
aiua-10978	129	3	.	.	PROPN
aiua-10978	130	1	2017	2017	NUM
aiua-10978	130	2	;	;	PUNCT
aiua-10978	130	3	72:389	72:389	NUM
aiua-10978	130	4	-	-	SYM
aiua-10978	130	5	399	399	NUM
aiua-10978	130	6	.	.	PUNCT
aiua-10978	131	1	10	10	NUM
aiua-10978	131	2	.	.	PUNCT
aiua-10978	132	1	yeowell	yeowell	INTJ
aiua-10978	132	2	g	g	PROPN
aiua-10978	132	3	,	,	PUNCT
aiua-10978	132	4	smith	smith	PROPN
aiua-10978	132	5	p	p	PROPN
aiua-10978	132	6	,	,	PUNCT
aiua-10978	132	7	nazir	nazir	PROPN
aiua-10978	132	8	j.	j.	PROPN
aiua-10978	132	9	et	et	PROPN
aiua-10978	132	10	al	al	PROPN
aiua-10978	132	11	.	.	PUNCT
aiua-10978	133	1	real	real	ADJ
aiua-10978	133	2	-	-	PUNCT
aiua-10978	133	3	world	world	NOUN
aiua-10978	133	4	persistence	persistence	NOUN
aiua-10978	133	5	and	and	CCONJ
aiua-10978	133	6	adherence	adherence	NOUN
aiua-10978	133	7	to	to	ADP
aiua-10978	133	8	oral	oral	ADJ
aiua-10978	133	9	antimuscarinics	antimuscarinic	NOUN
aiua-10978	133	10	and	and	CCONJ
aiua-10978	133	11	mirabegron	mirabegron	PROPN
aiua-10978	133	12	in	in	ADP
aiua-10978	133	13	patients	patient	NOUN
aiua-10978	133	14	with	with	ADP
aiua-10978	133	15	overactive	overactive	ADJ
aiua-10978	133	16	bladder	bladder	NOUN
aiua-10978	133	17	(	(	PUNCT
aiua-10978	133	18	oab	oab	PROPN
aiua-10978	133	19	):	):	PUNCT
aiua-10978	133	20	a	a	DET
aiua-10978	133	21	systemic	systemic	ADJ
aiua-10978	133	22	literature	literature	PROPN
aiua-10978	133	23	review	review	PROPN
aiua-10978	133	24	.	.	PUNCT
aiua-10978	134	1	bmj	bmj	PROPN
aiua-10978	134	2	open	open	ADJ
aiua-10978	134	3	.	.	PUNCT
aiua-10978	135	1	2018	2018	NUM
aiua-10978	135	2	;	;	PUNCT
aiua-10978	135	3	8	8	NUM
aiua-10978	135	4	:	:	PUNCT
aiua-10978	135	5	e021889	e021889	VERB
aiua-10978	135	6	.	.	PUNCT
aiua-10978	136	1	11	11	NUM
aiua-10978	136	2	.	.	PUNCT
aiua-10978	137	1	yamaguchi	yamaguchi	PROPN
aiua-10978	137	2	o	o	PROPN
aiua-10978	137	3	,	,	PUNCT
aiua-10978	137	4	ikeda	ikeda	PROPN
aiua-10978	137	5	y	y	PROPN
aiua-10978	137	6	,	,	PUNCT
aiua-10978	137	7	ohkawa	ohkawa	PROPN
aiua-10978	137	8	s.	s.	PROPN
aiua-10978	137	9	phase	phase	PROPN
aiua-10978	137	10	iii	iii	NUM
aiua-10978	137	11	study	study	NOUN
aiua-10978	137	12	to	to	PART
aiua-10978	137	13	assess	assess	VERB
aiua-10978	137	14	longterm	longterm	NOUN
aiua-10978	137	15	(	(	PUNCT
aiua-10978	137	16	52	52	NUM
aiua-10978	137	17	-	-	PUNCT
aiua-10978	137	18	week	week	NOUN
aiua-10978	137	19	)	)	PUNCT
aiua-10978	137	20	safety	safety	NOUN
aiua-10978	137	21	and	and	CCONJ
aiua-10978	137	22	efficacy	efficacy	NOUN
aiua-10978	137	23	of	of	ADP
aiua-10978	137	24	mirabegron	mirabegron	PROPN
aiua-10978	137	25	,	,	PUNCT
aiua-10978	137	26	a	a	DET
aiua-10978	137	27	β3	β3	ADJ
aiua-10978	137	28	-	-	PUNCT
aiua-10978	137	29	adrenoceptor	adrenoceptor	NOUN
aiua-10978	137	30	agonist	agonist	NOUN
aiua-10978	137	31	,	,	PUNCT
aiua-10978	137	32	in	in	ADP
aiua-10978	137	33	japanese	japanese	ADJ
aiua-10978	137	34	patients	patient	NOUN
aiua-10978	137	35	with	with	ADP
aiua-10978	137	36	overactive	overactive	ADJ
aiua-10978	137	37	bladder	bladder	NOUN
aiua-10978	137	38	.	.	PUNCT
aiua-10978	138	1	luts	luts	PROPN
aiua-10978	138	2	.	.	PROPN
aiua-10978	139	1	2017	2017	NUM
aiua-10978	139	2	;	;	PUNCT
aiua-10978	139	3	9:38	9:38	NUM
aiua-10978	139	4	-	-	SYM
aiua-10978	139	5	45	45	NUM
aiua-10978	139	6	.	.	PUNCT
aiua-10978	139	7	12	12	NUM
aiua-10978	139	8	.	.	PUNCT
aiua-10978	140	1	stöhrer	stöhrer	PROPN
aiua-10978	140	2	m	m	PROPN
aiua-10978	140	3	,	,	PUNCT
aiua-10978	140	4	madersbacher	madersbacher	PROPN
aiua-10978	140	5	h	h	NOUN
aiua-10978	140	6	,	,	PUNCT
aiua-10978	140	7	richter	richter	PROPN
aiua-10978	140	8	r	r	PROPN
aiua-10978	140	9	,	,	PUNCT
aiua-10978	140	10	et	et	PROPN
aiua-10978	140	11	al	al	PROPN
aiua-10978	140	12	.	.	PROPN
aiua-10978	140	13	efficacy	efficacy	NOUN
aiua-10978	140	14	and	and	CCONJ
aiua-10978	140	15	safety	safety	NOUN
aiua-10978	140	16	of	of	ADP
aiua-10978	140	17	propiverine	propiverine	NOUN
aiua-10978	140	18	in	in	ADP
aiua-10978	140	19	sci	sci	PROPN
aiua-10978	140	20	-	-	PUNCT
aiua-10978	140	21	patients	patient	NOUN
aiua-10978	140	22	suffering	suffer	VERB
aiua-10978	140	23	from	from	ADP
aiua-10978	140	24	detrusor	detrusor	NOUN
aiua-10978	140	25	hyperreflexia	hyperreflexia	NOUN
aiua-10978	140	26	-	-	PUNCT
aiua-10978	140	27	a	a	DET
aiua-10978	140	28	double	double	ADJ
aiua-10978	140	29	-	-	PUNCT
aiua-10978	140	30	blind	blind	ADJ
aiua-10978	140	31	,	,	PUNCT
aiua-10978	140	32	placebo	placebo	NOUN
aiua-10978	140	33	-	-	PUNCT
aiua-10978	140	34	controlled	control	VERB
aiua-10978	140	35	clinical	clinical	ADJ
aiua-10978	140	36	trial	trial	NOUN
aiua-10978	140	37	.	.	PUNCT
aiua-10978	141	1	spinal	spinal	ADJ
aiua-10978	141	2	cord	cord	NOUN
aiua-10978	141	3	.	.	PUNCT
aiua-10978	142	1	1999	1999	NUM
aiua-10978	142	2	;	;	PUNCT
aiua-10978	142	3	37:196	37:196	NUM
aiua-10978	142	4	-	-	SYM
aiua-10978	142	5	200	200	NUM
aiua-10978	142	6	.	.	NOUN
aiua-10978	143	1	13	13	NUM
aiua-10978	143	2	.	.	PUNCT
aiua-10978	144	1	nitti	nitti	PROPN
aiua-10978	144	2	vw	vw	PROPN
aiua-10978	144	3	,	,	PUNCT
aiua-10978	144	4	khullar	khullar	ADJ
aiua-10978	144	5	v	v	NOUN
aiua-10978	144	6	,	,	PUNCT
aiua-10978	144	7	van	van	PROPN
aiua-10978	144	8	kerrebroeck	kerrebroeck	PROPN
aiua-10978	144	9	p	p	PROPN
aiua-10978	144	10	,	,	PUNCT
aiua-10978	144	11	et	et	PROPN
aiua-10978	144	12	al	al	PROPN
aiua-10978	144	13	.	.	PROPN
aiua-10978	144	14	mirabegron	mirabegron	PROPN
aiua-10978	145	1	for	for	ADP
aiua-10978	145	2	the	the	DET
aiua-10978	145	3	treatment	treatment	NOUN
aiua-10978	145	4	of	of	ADP
aiua-10978	145	5	overactive	overactive	ADJ
aiua-10978	145	6	bladder	bladder	NOUN
aiua-10978	145	7	:	:	PUNCT
aiua-10978	145	8	a	a	DET
aiua-10978	145	9	prespecified	prespecifie	VERB
aiua-10978	145	10	pooled	pool	VERB
aiua-10978	145	11	efficacy	efficacy	NOUN
aiua-10978	145	12	analysis	analysis	NOUN
aiua-10978	145	13	and	and	CCONJ
aiua-10978	145	14	pooled	pool	VERB
aiua-10978	145	15	safety	safety	NOUN
aiua-10978	145	16	analysis	analysis	NOUN
aiua-10978	145	17	of	of	ADP
aiua-10978	145	18	three	three	NUM
aiua-10978	145	19	randomised	randomised	ADJ
aiua-10978	145	20	,	,	PUNCT
aiua-10978	145	21	doubleblind	doubleblind	NOUN
aiua-10978	145	22	,	,	PUNCT
aiua-10978	145	23	placebo	placebo	NOUN
aiua-10978	145	24	-	-	PUNCT
aiua-10978	145	25	controlled	control	VERB
aiua-10978	145	26	,	,	PUNCT
aiua-10978	145	27	phase	phase	NOUN
aiua-10978	145	28	iii	iii	NUM
aiua-10978	145	29	studies	study	NOUN
aiua-10978	145	30	.	.	PUNCT
aiua-10978	146	1	int	int	PROPN
aiua-10978	147	1	j	j	PROPN
aiua-10978	147	2	clin	clin	PROPN
aiua-10978	147	3	pract	pract	PROPN
aiua-10978	147	4	.	.	PUNCT
aiua-10978	148	1	2013	2013	NUM
aiua-10978	148	2	;	;	PUNCT
aiua-10978	148	3	67:619	67:619	NUM
aiua-10978	148	4	-	-	SYM
aiua-10978	148	5	632	632	NUM
aiua-10978	148	6	.	.	PUNCT
aiua-10978	149	1	14	14	NUM
aiua-10978	149	2	.	.	PUNCT
aiua-10978	150	1	wagg	wagg	PROPN
aiua-10978	150	2	a	a	PROPN
aiua-10978	150	3	,	,	PUNCT
aiua-10978	150	4	compion	compion	NOUN
aiua-10978	150	5	g	g	PROPN
aiua-10978	150	6	,	,	PUNCT
aiua-10978	150	7	fahey	fahey	PROPN
aiua-10978	150	8	a	a	PROPN
aiua-10978	150	9	,	,	PUNCT
aiua-10978	150	10	siddiqui	siddiqui	PROPN
aiua-10978	150	11	e.	e.	PROPN
aiua-10978	150	12	persistence	persistence	PROPN
aiua-10978	150	13	with	with	ADP
aiua-10978	150	14	prescribed	prescribe	VERB
aiua-10978	150	15	antimusucarinic	antimusucarinic	ADJ
aiua-10978	150	16	therapy	therapy	NOUN
aiua-10978	150	17	for	for	ADP
aiua-10978	150	18	overactive	overactive	ADJ
aiua-10978	150	19	bladder	bladder	NOUN
aiua-10978	150	20	:	:	PUNCT
aiua-10978	150	21	a	a	DET
aiua-10978	150	22	uk	uk	PROPN
aiua-10978	150	23	experience	experience	NOUN
aiua-10978	150	24	.	.	PUNCT
aiua-10978	151	1	buj	buj	PROPN
aiua-10978	151	2	int	int	PROPN
aiua-10978	151	3	.	.	PUNCT
aiua-10978	152	1	2012	2012	NUM
aiua-10978	152	2	;	;	PUNCT
aiua-10978	152	3	110:1767	110:1767	NOUN
aiua-10978	152	4	-	-	SYM
aiua-10978	152	5	1774	1774	NUM
aiua-10978	152	6	.	.	PUNCT
aiua-10978	153	1	15	15	NUM
aiua-10978	153	2	.	.	PUNCT
aiua-10978	154	1	wagg	wagg	PROPN
aiua-10978	154	2	a	a	PROPN
aiua-10978	154	3	,	,	PUNCT
aiua-10978	154	4	franks	franks	PROPN
aiua-10978	154	5	b	b	PROPN
aiua-10978	154	6	,	,	PUNCT
aiua-10978	154	7	ramos	ramos	PROPN
aiua-10978	154	8	b	b	PROPN
aiua-10978	154	9	,	,	PUNCT
aiua-10978	154	10	berner	berner	NOUN
aiua-10978	154	11	t.	t.	PROPN
aiua-10978	154	12	persistence	persistence	NOUN
aiua-10978	154	13	and	and	CCONJ
aiua-10978	154	14	adherence	adherence	NOUN
aiua-10978	154	15	with	with	ADP
aiua-10978	154	16	the	the	DET
aiua-10978	154	17	new	new	ADJ
aiua-10978	154	18	beta-3	beta-3	NUM
aiua-10978	154	19	receptor	receptor	NOUN
aiua-10978	154	20	agonist	agonist	NOUN
aiua-10978	154	21	,	,	PUNCT
aiua-10978	154	22	mirabegron	mirabegron	PROPN
aiua-10978	154	23	,	,	PUNCT
aiua-10978	154	24	versus	versus	ADP
aiua-10978	154	25	antimuscarinics	antimuscarinic	NOUN
aiua-10978	154	26	in	in	ADP
aiua-10978	154	27	overactive	overactive	ADJ
aiua-10978	154	28	bladder	bladder	NOUN
aiua-10978	154	29	:	:	PUNCT
aiua-10978	154	30	early	early	ADJ
aiua-10978	154	31	experience	experience	NOUN
aiua-10978	154	32	in	in	ADP
aiua-10978	154	33	canada	canada	PROPN
aiua-10978	154	34	.	.	PUNCT
aiua-10978	155	1	can	can	AUX
aiua-10978	155	2	urol	urol	VERB
aiua-10978	155	3	asso	asso	PROPN
aiua-10978	155	4	j.	j.	PROPN
aiua-10978	155	5	2015	2015	NUM
aiua-10978	155	6	;	;	PUNCT
aiua-10978	155	7	9:343	9:343	NUM
aiua-10978	155	8	-	-	SYM
aiua-10978	155	9	350	350	NUM
aiua-10978	155	10	.	.	PUNCT
aiua-10978	156	1	16	16	NUM
aiua-10978	156	2	.	.	PUNCT
aiua-10978	157	1	sussman	sussman	PROPN
aiua-10978	157	2	d	d	PROPN
aiua-10978	157	3	,	,	PUNCT
aiua-10978	157	4	yehoshua	yehoshua	PROPN
aiua-10978	157	5	a	a	PRON
aiua-10978	157	6	,	,	PUNCT
aiua-10978	157	7	kowalski	kowalski	PROPN
aiua-10978	157	8	j	j	PROPN
aiua-10978	157	9	,	,	PUNCT
aiua-10978	157	10	et	et	PROPN
aiua-10978	157	11	al	al	PROPN
aiua-10978	157	12	.	.	PROPN
aiua-10978	157	13	adherence	adherence	NOUN
aiua-10978	157	14	and	and	CCONJ
aiua-10978	157	15	persistence	persistence	NOUN
aiua-10978	157	16	of	of	ADP
aiua-10978	157	17	mirabegron	mirabegron	ADJ
aiua-10978	157	18	and	and	CCONJ
aiua-10978	157	19	anticholinergic	anticholinergic	ADJ
aiua-10978	157	20	therapies	therapy	NOUN
aiua-10978	157	21	in	in	ADP
aiua-10978	157	22	patients	patient	NOUN
aiua-10978	157	23	with	with	ADP
aiua-10978	157	24	overactive	overactive	ADJ
aiua-10978	157	25	bladder	bladder	NOUN
aiua-10978	157	26	:	:	PUNCT
aiua-10978	157	27	a	a	DET
aiua-10978	157	28	real	real	ADJ
aiua-10978	157	29	-	-	PUNCT
aiua-10978	157	30	world	world	NOUN
aiua-10978	157	31	claims	claim	NOUN
aiua-10978	157	32	data	datum	NOUN
aiua-10978	157	33	analysis	analysis	NOUN
aiua-10978	157	34	.	.	PUNCT
aiua-10978	158	1	int	int	PROPN
aiua-10978	159	1	j	j	PROPN
aiua-10978	159	2	clin	clin	PROPN
aiua-10978	159	3	prac	prac	PROPN
aiua-10978	159	4	.	.	PROPN
aiua-10978	159	5	2017	2017	NUM
aiua-10978	159	6	;	;	PUNCT
aiua-10978	159	7	71	71	NUM
aiua-10978	159	8	:	:	PUNCT
aiua-10978	159	9	e12824	e12824	NOUN
aiua-10978	159	10	.	.	PROPN
aiua-10978	159	11	17	17	NUM
aiua-10978	159	12	.	.	PUNCT
aiua-10978	160	1	kalder	kalder	PROPN
aiua-10978	160	2	m	m	PROPN
aiua-10978	160	3	,	,	PUNCT
aiua-10978	160	4	pantazis	pantazi	VERB
aiua-10978	160	5	k	k	PROPN
aiua-10978	160	6	,	,	PUNCT
aiua-10978	160	7	dinas	dinas	PROPN
aiua-10978	160	8	k	k	PROPN
aiua-10978	160	9	,	,	PUNCT
aiua-10978	160	10	et	et	PROPN
aiua-10978	160	11	al	al	PROPN
aiua-10978	160	12	.	.	PUNCT
aiua-10978	161	1	discontinuation	discontinuation	NOUN
aiua-10978	161	2	of	of	ADP
aiua-10978	161	3	treatment	treatment	NOUN
aiua-10978	161	4	using	use	VERB
aiua-10978	161	5	anticholinergic	anticholinergic	ADJ
aiua-10978	161	6	medications	medication	NOUN
aiua-10978	161	7	in	in	ADP
aiua-10978	161	8	patients	patient	NOUN
aiua-10978	161	9	with	with	ADP
aiua-10978	161	10	urinary	urinary	ADJ
aiua-10978	161	11	incontinence	incontinence	NOUN
aiua-10978	161	12	.	.	PUNCT
aiua-10978	162	1	obstet	obstet	PROPN
aiua-10978	162	2	gynecol	gynecol	PROPN
aiua-10978	162	3	.	.	PUNCT
aiua-10978	162	4	2014	2014	NUM
aiua-10978	162	5	;	;	PUNCT
aiua-10978	162	6	124:794	124:794	PROPN
aiua-10978	162	7	-	-	PUNCT
aiua-10978	162	8	800	800	NUM
aiua-10978	162	9	.	.	PUNCT
aiua-10978	162	10	18	18	NUM
aiua-10978	162	11	.	.	PUNCT
aiua-10978	163	1	wada	wada	PROPN
aiua-10978	163	2	n	n	CCONJ
aiua-10978	163	3	,	,	PUNCT
aiua-10978	163	4	watanabe	watanabe	PROPN
aiua-10978	163	5	m	m	PROPN
aiua-10978	163	6	,	,	PUNCT
aiua-10978	163	7	banjo	banjo	NOUN
aiua-10978	163	8	h	h	PROPN
aiua-10978	163	9	,	,	PUNCT
aiua-10978	163	10	et	et	PROPN
aiua-10978	163	11	al	al	PROPN
aiua-10978	163	12	.	.	PUNCT
aiua-10978	164	1	long	long	ADJ
aiua-10978	164	2	-	-	PUNCT
aiua-10978	164	3	term	term	NOUN
aiua-10978	164	4	persistence	persistence	NOUN
aiua-10978	164	5	with	with	ADP
aiua-10978	164	6	mirabegron	mirabegron	PROPN
aiua-10978	164	7	in	in	ADP
aiua-10978	164	8	a	a	DET
aiua-10978	164	9	real	real	ADJ
aiua-10978	164	10	-	-	PUNCT
aiua-10978	164	11	world	world	NOUN
aiua-10978	164	12	clinical	clinical	ADJ
aiua-10978	164	13	setting	setting	NOUN
aiua-10978	164	14	.	.	PUNCT
aiua-10978	165	1	int	int	NOUN
aiua-10978	165	2	j	j	PROPN
aiua-10978	165	3	urol	urol	PROPN
aiua-10978	165	4	.	.	PUNCT
aiua-10978	166	1	2018	2018	NUM
aiua-10978	166	2	;	;	PUNCT
aiua-10978	166	3	25:501	25:501	NUM
aiua-10978	166	4	-	-	SYM
aiua-10978	166	5	506	506	NUM
aiua-10978	166	6	.	.	NOUN
aiua-10978	166	7	19	19	NUM
aiua-10978	166	8	.	.	PUNCT
aiua-10978	167	1	dejong	dejong	PROPN
aiua-10978	167	2	c	c	PROPN
aiua-10978	167	3	,	,	PUNCT
aiua-10978	167	4	aguilar	aguilar	PROPN
aiua-10978	167	5	t	t	PROPN
aiua-10978	167	6	,	,	PUNCT
aiua-10978	167	7	tseng	tseng	PROPN
aiua-10978	167	8	cw	cw	PROPN
aiua-10978	167	9	,	,	PUNCT
aiua-10978	167	10	et	et	PROPN
aiua-10978	167	11	al	al	PROPN
aiua-10978	167	12	.	.	PROPN
aiua-10978	167	13	pharmaceutical	pharmaceutical	PROPN
aiua-10978	167	14	industry	industry	NOUN
aiua-10978	167	15	–	–	PUNCT
aiua-10978	167	16	sponsored	sponsor	VERB
aiua-10978	167	17	meals	meal	NOUN
aiua-10978	167	18	and	and	CCONJ
aiua-10978	167	19	physician	physician	NOUN
aiua-10978	167	20	prescribing	prescribing	NOUN
aiua-10978	167	21	patterns	pattern	NOUN
aiua-10978	167	22	for	for	ADP
aiua-10978	167	23	medicare	medicare	PROPN
aiua-10978	167	24	beneficiaries	beneficiary	NOUN
aiua-10978	167	25	jama	jama	PROPN
aiua-10978	167	26	intern	intern	NOUN
aiua-10978	167	27	med	me	VERB
aiua-10978	167	28	.	.	PROPN
aiua-10978	167	29	2016	2016	NUM
aiua-10978	167	30	;	;	PUNCT
aiua-10978	167	31	176:1114	176:1114	X
aiua-10978	167	32	-	-	SYM
aiua-10978	167	33	1122	1122	NUM
aiua-10978	167	34	.	.	PUNCT
aiua-10978	168	1	correspondence	correspondence	NOUN
aiua-10978	168	2	hiroshi	hiroshi	PROPN
aiua-10978	168	3	masuda	masuda	PROPN
aiua-10978	168	4	,	,	PUNCT
aiua-10978	168	5	md	md	PROPN
aiua-10978	168	6	,	,	PUNCT
aiua-10978	168	7	phd	phd	NOUN
aiua-10978	168	8	(	(	PUNCT
aiua-10978	168	9	corresponding	correspond	VERB
aiua-10978	168	10	author	author	NOUN
aiua-10978	168	11	)	)	PUNCT
aiua-10978	168	12	hrsmasuda@yahoo.co.jp	hrsmasuda@yahoo.co.jp	PROPN
aiua-10978	168	13	kosuke	kosuke	PROPN
aiua-10978	168	14	mikami	mikami	PROPN
aiua-10978	168	15	,	,	PUNCT
aiua-10978	168	16	md	md	PROPN
aiua-10978	168	17	kotaro	kotaro	PROPN
aiua-10978	168	18	otsuka	otsuka	PROPN
aiua-10978	168	19	,	,	PUNCT
aiua-10978	168	20	md	md	PROPN
aiua-10978	168	21	kyokusin	kyokusin	PROPN
aiua-10978	168	22	hou	hou	PROPN
aiua-10978	168	23	,	,	PUNCT
aiua-10978	168	24	md	md	PROPN
aiua-10978	168	25	takahito	takahito	PROPN
aiua-10978	168	26	suyama	suyama	PROPN
aiua-10978	168	27	,	,	PUNCT
aiua-10978	168	28	md	md	PROPN
aiua-10978	168	29	kazuhiro	kazuhiro	PROPN
aiua-10978	168	30	araki	araki	PROPN
aiua-10978	168	31	,	,	PUNCT
aiua-10978	168	32	md	md	PROPN
aiua-10978	168	33	satoko	satoko	PROPN
aiua-10978	168	34	kojima	kojima	PROPN
aiua-10978	168	35	,	,	PUNCT
aiua-10978	168	36	md	md	PROPN
aiua-10978	168	37	yukio	yukio	PROPN
aiua-10978	168	38	naya	naya	PROPN
aiua-10978	168	39	,	,	PUNCT
aiua-10978	168	40	md	md	PROPN
aiua-10978	168	41	department	department	PROPN
aiua-10978	168	42	of	of	ADP
aiua-10978	168	43	urology	urology	NOUN
aiua-10978	168	44	,	,	PUNCT
aiua-10978	168	45	teikyo	teikyo	PROPN
aiua-10978	168	46	university	university	PROPN
aiua-10978	168	47	chiba	chiba	PROPN
aiua-10978	168	48	medical	medical	PROPN
aiua-10978	168	49	center	center	NOUN
aiua-10978	168	50	,	,	PUNCT
aiua-10978	168	51	3426	3426	NUM
aiua-10978	168	52	-	-	SYM
aiua-10978	168	53	3	3	NUM
aiua-10978	168	54	anesaki	anesaki	NOUN
aiua-10978	168	55	,	,	PUNCT
aiua-10978	168	56	ichihara	ichihara	PROPN
aiua-10978	168	57	,	,	PUNCT
aiua-10978	168	58	chiba	chiba	PROPN
aiua-10978	168	59	,	,	PUNCT
aiua-10978	168	60	299	299	NUM
aiua-10978	168	61	-	-	SYM
aiua-10978	168	62	0111	0111	NUM
aiua-10978	168	63	,	,	PUNCT
aiua-10978	168	64	japan	japan	PROPN